GloveMFG

A container of medical nitrile gloves held at a US port of entry costs you roughly $3,000–$8,000 in demurrage before you've resolved anything. If the FDA detains the shipment for examination, add 2–6 weeks of delay and the real possibility of refusal of admission. The gloves go back to the factory or get destroyed. Your customer doesn't get their order. You absorb the loss.

Most of these rejections aren't caused by defective gloves. They're caused by documentation that doesn't match the product in the container — a 510(k) clearance number that covers a different glove model, a CE certificate that expired six months before shipment, or an AQL test report that references a lot number nobody can trace to the actual production run.

We've handled pre-shipment compliance documentation for US, Canadian, and European healthcare distributors for over a decade. The failures we see aren't random. They follow predictable patterns, and most of them are preventable if you know what to check before the container is sealed.

Why certification scope mismatches cause most port rejections

FDA 510(k) clearance is product-specific. The clearance number on your supplier's documentation covers the exact device described in the 510(k) submission — specific material formulation, thickness range, intended use, and labeling claims. When a factory changes its nitrile compound, adjusts the thickness spec, or starts producing a new SKU under the same brand name, that new product may not be covered by the original clearance.

This is where importers get caught. The factory sends you a 510(k) number — K-prefix, six digits — and it looks legitimate because it is legitimate. It just doesn't cover what's in your container.

The FDA's 510(k) database is public. Before your container ships, pull up the clearance record at accessdata.fda.gov and confirm:

• The device name in the clearance record matches the product description on your invoice and labeling
• The applicant or owner matches your supplier (or that a valid transfer of ownership is documented)
• The intended use covers medical examination — not just industrial or food-contact use
• The clearance is not subject to a Class I or Class II recall (check the FDA recall database separately)

(We've seen factories list a 510(k) number on their spec sheet that was cleared for a different glove line entirely — same brand, different product. The FDA doesn't care that it was an honest mistake.)

For the EU market, CE marking under the Medical Devices Regulation (MDR 2017/745) requires a Notified Body certificate for Class I medical devices. EN 455 is the harmonized standard — four parts covering dimensions, penetration resistance, biological evaluation, and shelf life. Ask your supplier for the full EN 455 test report, not just the CE declaration of conformity. The declaration tells you the manufacturer claims compliance. The test report tells you whether the gloves actually passed.

The five documents you need before the container is sealed

This is the minimum documentation set for a medical nitrile glove shipment into the US or EU. Missing any one of these creates a gap that customs or port health authorities can use to hold or reject the shipment.

1. FDA 510(k) clearance letter (US market) The original clearance letter, not a summary page. Confirm the K-number, device description, and that the clearance is current (not withdrawn). Cross-reference against the FDA database — don't rely solely on what the factory provides.

2. EN 455 test report + CE certificate (EU/UK market) The test report must cover all four parts of EN 455. The CE certificate must be issued by an accredited Notified Body, not self-declared. Check the certificate expiry date — EN 455 certificates typically run 3–5 years, and factories don't always proactively notify buyers when they're approaching renewal.

3. AQL 1.5 inspection report tied to the production lot The AQL report must reference the specific lot number being shipped. A generic AQL report from a previous production run doesn't satisfy FDA or EU import requirements for lot traceability. The report should show sample size, acceptance number, rejection number, and actual defects found — not just a pass/fail stamp.

4. Certificate of Conformance (CoC) Issued by the factory for the specific shipment, referencing lot number, quantity, product specification, and the certifications the product is manufactured under. This is the document that ties everything together at customs.

5. Labeling compliance confirmation For FDA-regulated medical gloves, labeling must comply with 21 CFR Part 801. For EU, labeling must meet MDR Annex I requirements. Ask the factory to provide a labeling sample or proof before production is finalized — not after the container is packed.

How to verify AQL reports aren't recycled from a previous lot

This is the most common documentation fraud we encounter — not forged certificates, but legitimate test reports from a real inspection that get reused across multiple shipments. The factory ran AQL 1.5 on a production lot six months ago, passed, and now attaches that same report to every container regardless of when the gloves were actually made.

Here's how to catch it:

• Match the lot number on the AQL report to the lot number on the packing list and CoC. If they don't match, stop. Ask for the report that corresponds to the actual lot being shipped.
• Check the inspection date against the production date. The inspection should follow production, not precede it by months.
• Ask who conducted the inspection. Factory self-inspection is acceptable for routine production monitoring, but for first orders or after any production change, request a third-party AQL report from SGS, Bureau Veritas, Intertek, or equivalent.
• Look at the sample size. For a standard 2,000-box container (approximately 200,000 gloves), AQL 1.5 at inspection level II requires a sample size of around 200 units minimum. If the report shows a sample of 32 units for a full container, the inspection level doesn't match the shipment volume.

We run 100% online pinhole detection on our dipping lines and conduct AQL 1.5 on every production lot before it leaves the floor. When a buyer asks for the lot-specific report, we pull it from the same batch record that tracks compound formulation, line number, and production date. That traceability is what makes the document useful — a report without a traceable lot number is just paper.

Accelerator-free certification: what EU hospital buyers are actually asking for

If you're supplying European hospital procurement or any healthcare account with sensitization protocols, you'll encounter requests for accelerator-free certification. This is separate from EN 455 and CE marking — it's a formulation claim, not a device classification.

Standard nitrile gloves use thiuram and carbamate accelerators in the vulcanization process. These compounds are associated with Type IV (delayed) hypersensitivity reactions in healthcare workers. EU hospital procurement increasingly specifies accelerator-free nitrile as a condition of supply, particularly in Scandinavia, Germany, and France.

What to verify:

• Ask for the compound specification sheet confirming the glove is manufactured without thiuram, carbamate, and mercaptobenzothiazole (MBT) accelerators
• Ask whether the accelerator-free claim is supported by a chemical analysis report (HPLC or equivalent) — not just a factory declaration
• Confirm the claim covers the specific SKU being ordered, not just the factory's accelerator-free product line in general

(We developed our accelerator-free compound in-house specifically for European hospital accounts. The formulation is tested by third-party lab before each production campaign — not just once at initial development. That matters because compound batches can vary, and a single historical test doesn't guarantee the current production run is clean.)

What ASTM D6319 covers — and what it doesn't

For US distributors supplying industrial or food-processing accounts alongside medical accounts, ASTM D6319 comes up regularly. It's the standard specification for nitrile examination gloves for medical application — tensile strength, elongation, force at break, and dimensional requirements.

ASTM D6319 compliance is not the same as FDA 510(k) clearance. A glove can pass ASTM D6319 testing and still not be FDA-cleared as a medical device. The distinction matters when your customer is a hospital or clinic that requires FDA-cleared examination gloves — ASTM compliance alone won't satisfy their procurement requirements.

Conversely, a 510(k)-cleared glove will typically have ASTM D6319 test data as part of its technical file, so if you have the 510(k) clearance letter, the ASTM compliance is generally implied. Ask for the test data anyway — it gives you the actual tensile and elongation numbers, which matter if your customer has specific performance specs.

Standard	Market	What it covers	What it doesn't cover
FDA 510(k)	US	Medical device clearance	Specific lot quality
EN 455 (Parts 1–4)	EU/UK	Dimensions, penetration, biocompatibility, shelf life	Accelerator content
ASTM D6319	US	Tensile, elongation, dimensions	Device regulatory status
CE (MDR)	EU	Device classification and conformity	Lot-level inspection
ISO 9001:2015	Global	Quality management system	Product performance

The labeling trap that holds containers at EU ports

EU customs authorities check labeling before they check test reports. A container of medical nitrile gloves with non-compliant labeling gets flagged before anyone looks at your EN 455 certificate.

MDR Annex I requires, at minimum:

• Manufacturer name and address
• Device name and intended purpose
• "Sterile" designation if applicable (most examination gloves are non-sterile — confirm this is stated)
• Lot or batch number
• Expiry date (EN 455-4 requires shelf-life validation — the date on the box must be supported by real aging data)
• Size designation
• Quantity per box
• Single-use designation (symbol or text)
• CE marking with Notified Body number

The expiry date requirement catches buyers off guard. A factory can print any date on the box. What matters is whether that date is supported by EN 455-4 shelf-life testing — accelerated aging or real-time aging data showing the gloves maintain performance through the stated shelf life. Ask for the aging test report. If the factory can't produce it, the expiry date on the box is unsubstantiated, and that's a labeling non-compliance.

For US labeling under 21 CFR Part 801, the requirements are similar but not identical. The FDA requires the intended use to be stated, the manufacturer or distributor name and address, and adequate directions for use (or an exemption). Latex-free claims require supporting test data — if your gloves are labeled "latex-free," the factory needs to show the test.

Upstream prevention: what to lock in before production starts

Port rejections are downstream events. The decisions that cause them happen weeks earlier — at the point of order confirmation, specification sign-off, and production scheduling.

Before production begins, confirm in writing:

• Which 510(k) clearance number covers this specific SKU — not the factory's general product line, this exact product
• Which EN 455 certificate covers this SKU — and its expiry date
• The compound formulation — standard accelerator or accelerator-free, and which third-party test supports the claim
• The AQL inspection plan — who conducts it, at what level, and that the report will reference the production lot number
• The labeling artwork — reviewed and approved before printing, not after the boxes are packed

We require labeling artwork sign-off before we schedule production. It adds a step, but it eliminates the scenario where 50,000 boxes are packed with a label error that requires reprinting or relabeling at destination — which is expensive and sometimes triggers a customs query about why the labeling was changed post-production.

The other thing worth locking in early: shelf-life alignment. If you're ordering for a customer who needs 24 months of remaining shelf life at delivery, confirm the production date and the stated expiry date before the order is placed. A factory that prints a 3-year expiry on gloves produced in January needs EN 455-4 data supporting that claim through January three years out. If the aging data only supports 2 years, the 3-year date is non-compliant regardless of what's printed on the box.

Common mistakes that cause rejections — and how to prevent them

Relying on a factory's certification summary sheet instead of the source documents Summary sheets are marketing materials. Pull the actual 510(k) clearance letter from the FDA database. Request the full EN 455 test report, not the one-page certificate. The details that matter — device scope, test parameters, lot traceability — are in the source documents.

Not checking certificate expiry dates EN 455 certificates expire. CE certificates expire. A certificate that was valid when you first qualified the supplier may have lapsed by the time your third or fourth container ships. Build a simple expiry tracking sheet for every supplier's certifications and check it before each order.

Accepting AQL reports without lot traceability If the AQL report doesn't reference the specific lot being shipped, it's not useful for import compliance. Require lot-specific documentation as a condition of shipment release.

Assuming FDA clearance covers all sizes and colors Some 510(k) clearances are size-specific or cover only certain configurations. If you're ordering a new size or a new color variant from a supplier, confirm the clearance covers that variant before the order is placed.

Not verifying the 510(k) transfer when a factory changes ownership or brand 510(k) clearances are transferable, but the transfer must be documented with the FDA. If your supplier was acquired, rebranded, or changed its legal entity, verify that the clearance was properly transferred. An undocumented transfer means the clearance technically belongs to the previous entity.

Practical FAQ

Can a factory's ISO 9001 certification substitute for FDA 510(k) or EN 455? No. ISO 9001 certifies the quality management system — the processes the factory uses to control production. It says nothing about whether the product itself meets medical device performance requirements. FDA 510(k) and EN 455 are product certifications. You need both: a quality system that produces consistent output, and product certifications that confirm the output meets the required standard.

What's the difference between a CE Declaration of Conformity and a Notified Body certificate? A Declaration of Conformity is a self-declaration by the manufacturer that the product meets applicable EU requirements. For Class I medical devices (which includes most non-sterile examination gloves), a Notified Body is not required for the conformity assessment itself — but EN 455 testing must still be conducted and documented. If your supplier claims CE marking without any EN 455 test reports, that's a red flag. Ask for the technical file summary and the test reports.

How do I verify a 510(k) clearance number is legitimate? Go to accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm and search by the K-number. The database is public and updated in real time. If the number doesn't appear, or the device description doesn't match your product, the clearance doesn't cover what you're buying.

What should I do if a supplier can't provide lot-specific AQL documentation? Arrange a third-party pre-shipment inspection through SGS, Bureau Veritas, or Intertek before the container is sealed. The cost — typically $300–$600 for a standard container inspection — is a fraction of the demurrage and delay cost if the shipment is held at port.

—

If you're sourcing medical nitrile gloves and want to confirm that the documentation package covers your target market — US, EU, or both — send us your requirements. We'll walk through the certification scope, lot documentation, and labeling requirements for your specific SKU before production is scheduled. Request a quote or documentation review and we'll respond with the relevant compliance documentation for your market.

The question lands in procurement inboxes constantly: nitrile or latex? On the surface it looks like a material preference. In practice, it's a liability decision, a compliance decision, and a landed-cost decision rolled into one — and the wrong call costs more than the price difference on the invoice.

Latex has been the default in medical settings for decades. It's elastic, tactile, and well-understood. Nitrile displaced it in most high-volume healthcare markets not because it's cheaper per pair, but because the downstream cost of latex allergy incidents — staff replacement, incident documentation, legal exposure — made latex the more expensive option at scale. That shift happened in North America and Western Europe over the past 20 years. It's still happening in Southeast Asia and parts of the Middle East.

Quick verdict: For any distributor supplying hospitals, clinics, or dental practices in regulated markets, nitrile is the defensible default. Latex still wins in specific surgical and high-dexterity applications where its elastic properties are genuinely irreplaceable — but those are narrowing use cases, not growth segments.

—

Allergy Risk: The Liability That Doesn't Show Up on the Price Sheet

This is where the comparison starts, because it's where the hidden cost lives.

Natural rubber latex contains proteins — specifically Hevea brasiliensis proteins — that trigger Type I IgE-mediated hypersensitivity in sensitized individuals. Type I latex allergy is not a rash. It's systemic: urticaria, bronchospasm, anaphylaxis. In a clinical setting, a Type I reaction during a procedure is a medical emergency and a liability event. The prevalence of latex sensitization in healthcare workers runs between 8–17% in studies across the US and Europe (higher in populations with repeated exposure). Your hospital buyer's occupational health department knows this number. Their legal team knows it too.

Nitrile is synthetic. No Hevea proteins, no Type I allergy pathway. That's the clean answer for most buyers.

The complication is Type IV — delayed hypersensitivity to chemical accelerators used in the vulcanization process. Thiurams, carbamates, and mercaptobenzothiazole are the common culprits. Type IV reactions present as contact dermatitis: localized, delayed, not life-threatening, but chronic and disruptive for clinical staff. Standard nitrile gloves contain these accelerators. Accelerator-free nitrile eliminates the Type IV pathway entirely — it uses a different crosslinking chemistry (typically sulfur-free or carbamate-free formulations) that produces a glove with no detectable accelerator residue.

We've been producing accelerator-free nitrile since European hospital procurement started specifying it seriously — roughly 2018 onward in the French and German markets. The compound formulation is different, the cure cycle is longer, and the cost is higher. But for buyers supplying dermatology units, surgical teams, or any facility with documented accelerator sensitivity cases, it's not optional.

(Note: if your target accounts include European public hospital tenders, accelerator-free compliance is increasingly a bid requirement, not a differentiator. Verify before you quote.)

—

Head-to-Head: Barrier Performance, Physical Properties, and Compliance Specs

Property	Medical Nitrile	Natural Rubber Latex
Allergy profile	No Type I; Type IV if accelerators present	Type I (Hevea proteins); Type IV possible
Accelerator-free option	Yes — available from specialized manufacturers	No — latex vulcanization requires accelerators
Tensile strength	High — typically 14–18 MPa	Very high — typically 18–24 MPa
Elongation at break	500–600%	700–800%
Puncture resistance	Superior — 3–4× higher than latex at equivalent thickness	Lower — thinner walls puncture more easily
Chemical resistance	Excellent — oils, solvents, many chemotherapy agents	Moderate — degrades with oils and many solvents
Fit and tactile feel	Good — improves with thinner formulations	Excellent — natural elasticity conforms closely
Shelf life	5 years (standard)	3 years (degrades faster)
Regulatory compliance	FDA 510(k), CE, EN 455, ASTM D6319	FDA 510(k), CE, EN 455 available
Powder-free availability	Standard — all medical grade	Available but less common
Relative unit cost	Moderate — stable synthetic feedstock	Variable — natural rubber commodity pricing

The tensile and elongation numbers favor latex on paper. In practice, the puncture resistance gap is what matters in clinical settings — a nitrile glove at 0.10mm holds up better against needle sticks and sharp instrument contact than a latex glove at the same nominal thickness. We run our medical-grade nitrile at 0.08–0.12mm palm thickness with online pinhole detection on every line. A glove that passes AQL 1.5 at our facility has been tested more rigorously than most of what's moving through spot-buy channels.

The shelf life difference is commercially meaningful for distributors managing warehouse inventory. Latex degrades faster — the natural rubber oxidizes, and you'll see tensile loss and surface tackiness in older stock. Nitrile holds spec for five years under standard storage conditions, so your slow-moving SKUs don't become a write-off problem.

—

The Hidden Cost Analysis: What the Per-Box Price Doesn't Tell You

Latex looks cheaper on a per-box basis in many sourcing markets — particularly when natural rubber prices are low. That comparison breaks down the moment you account for downstream costs.

Allergy incident cost: A documented Type I latex reaction in a clinical setting triggers incident reporting, potential worker's compensation, possible legal action, and staff reassignment. The direct cost of a single serious incident can run into five figures. Multiply that across a hospital system with 500 clinical staff and a 10% sensitization rate, and the risk premium on latex is not theoretical.

Compliance cost in regulated markets: FDA-cleared latex gloves exist, but the regulatory trend in North America and Europe has moved toward nitrile as the default medical-grade material. Some hospital procurement frameworks now require documented latex-free supply chains. If your buyer operates in a system with that requirement, latex isn't a cost-saving option — it's a disqualification.

Inventory write-off risk: Latex's 3-year shelf life versus nitrile's 5-year shelf life is a real inventory management difference. A distributor holding 12 months of safety stock in latex is carrying a product that ages out faster. In the COVID-era supply disruptions, we saw buyers who had over-ordered latex end up with out-of-spec stock they couldn't move. Nitrile held spec through extended storage.

Chemical resistance in procedure-specific use: Latex degrades on contact with oils and many solvents. In any procedure involving lubricants, certain disinfectants, or chemotherapy drug handling, latex gloves lose barrier integrity faster. A glove failure during chemo drug preparation is a serious exposure event. Nitrile's chemical resistance profile eliminates that failure mode.

(We've had buyers come to us after a latex-related incident at a customer facility. The conversation is always the same: the per-box savings weren't worth it. The switch to nitrile happened immediately after.)

—

Application Showdown: Which Option Wins in Real Procurement Scenarios

Scenario 1: Hospital System Supply Contract — High Volume, Regulated Market

Winner: Medical nitrile, accelerator-free specification for surgical and procedure units.

A hospital system in North America or Western Europe running 50,000–200,000 gloves per month needs a supply chain that won't generate incident reports. The allergy liability alone makes latex the wrong default. Accelerator-free nitrile covers both Type I and Type IV exposure, satisfies occupational health requirements, and holds spec in warehouse inventory for five years. The per-box premium over standard nitrile is real but small relative to the compliance value. Our FDA 510(k) clearance and EN 455 certification cover both markets from a single SKU.

Scenario 2: Dental Practice Distribution — Mid-Volume, Price-Sensitive

Winner: Standard medical nitrile.

Dental distributors serving independent practices are price-sensitive but can't afford allergy incidents with staff or patients. Standard powder-free nitrile at AQL 1.5 is the right spec — it eliminates latex allergy risk, passes FDA requirements, and lands at a price point that works for the practice's supply budget. Accelerator-free is available as an upsell for practices that have documented sensitivity cases, but it's not the default SKU for this segment.

Scenario 3: Emerging Market Healthcare Distribution — Cost-Driven, Less Regulated

Winner: Nitrile, but the case requires more explanation.

In markets where latex is still the incumbent and price pressure is high, the switch to nitrile requires a commercial argument, not just a compliance argument. The shelf life advantage, the puncture resistance data, and the long-term staff sensitization risk are the right levers. Latex may still move in this segment, but distributors building a durable business in healthcare supply are better positioned with nitrile — the regulatory direction is clear, and the allergy liability doesn't disappear just because local enforcement is lighter.

—

What to Verify Before You Source Either Option

The certification on the box and the quality in the container are two different things. This is the part of the conversation that most sourcing guides skip.

For nitrile: Verify that the FDA 510(k) clearance number on the packaging matches the actual cleared device. 510(k) clearance is product-specific — a manufacturer can't apply one clearance number to a different formulation or thickness. Ask for the 510(k) summary document and cross-reference the device description. If the glove thickness or formulation in the summary doesn't match what you're buying, the clearance doesn't apply.

For accelerator-free nitrile: Ask for the test report, not just the claim. Accelerator-free is a formulation specification — it should be supported by chemical analysis (typically EN ISO 17075 or equivalent) showing non-detectable levels of the relevant accelerators. A label that says "accelerator-free" without a test report is a marketing claim, not a compliance document.

For latex: Verify the protein content testing. EN 455-3 requires protein content testing for latex medical gloves. Low-protein latex reduces (but does not eliminate) Type I sensitization risk. Ask for the lot-specific test results, not just the product certification.

AQL standard: Medical-grade gloves should be inspected to AQL 1.5. AQL 2.5 is the industrial standard — it allows more defects per lot. If a supplier quotes you "medical grade" at AQL 2.5, that's a mismatch. We run 100% AQL 1.5 with online pinhole detection on all eight lines. Every lot that ships has a corresponding inspection report.

RFQ language that protects you: When you send an RFQ for medical nitrile, specify: powder-free, AQL 1.5, FDA 510(k) cleared (provide the clearance number), EN 455 certified, and — if required — accelerator-free with supporting chemical analysis. That specification language filters out suppliers who can't actually deliver compliant product.

—

Scenario-Based Selection Guide

Your situation	Recommended option
Hospital/clinic supply in US or EU	Accelerator-free medical nitrile
Dental distribution, standard spec	Powder-free medical nitrile, AQL 1.5
Surgical glove replacement (high dexterity required)	Latex (nitrile improving but not equivalent)
Chemo drug handling / chemical exposure	Nitrile — latex degrades with solvents
Long-term warehouse inventory	Nitrile — 5-year shelf life vs 3-year latex
Emerging market, price-sensitive, no latex mandate	Nitrile — allergy liability exists regardless of regulation
Documented accelerator sensitivity in end-user facility	Accelerator-free nitrile — standard nitrile doesn't solve this

For most distributors reading this, the answer is nitrile — the question is which specification. If you're supplying Medical Nitrile Gloves into regulated healthcare markets, the compliance documentation matters as much as the glove itself. If you're not sure which spec fits your accounts, send us your target market and volume — we'll match the formulation to your compliance requirements and send back a quote with the relevant certification documents included.

Hospital procurement teams in Germany, France, and the Netherlands have been quietly tightening their glove specifications for the past several years. The change doesn't show up as a headline — it shows up as a line item in tender documents: accelerator-free formulation required. If your current supplier can't meet that line item, you lose the bid.

This article explains what accelerator-free nitrile gloves actually are at the formulation level, which standards govern them, and what you need to verify before committing to a container order. If you're sourcing Medical Nitrile Gloves for hospital or clinic distribution, this is the compliance layer that's increasingly separating approved vendors from rejected ones.

—

What "Accelerator-Free" Actually Means at the Compound Level

Standard nitrile gloves are vulcanized — the raw nitrile latex is cross-linked using sulfur-based chemical accelerators, most commonly thiurams, dithiocarbamates, and mercaptobenzothiazole (MBT). These accelerators make the curing process faster and more controllable, and they've been the industry standard for decades.

The problem is residue. Even after curing, trace amounts of these accelerators remain in the finished glove. For most wearers, that's irrelevant. For a subset of healthcare workers — estimates in European occupational health literature typically run between 5% and 17% of regular glove users — those residues trigger a delayed hypersensitivity reaction known as Type IV contact dermatitis.

Type IV is not the same as latex allergy (which is a Type I IgE-mediated response). It's a T-cell-mediated reaction that develops over 24–72 hours after exposure: redness, vesicles, cracking skin, sometimes progressing to chronic eczema. It's occupational, cumulative, and in severe cases career-ending for clinical staff.

Accelerator-free nitrile eliminates the trigger. The compound is cross-linked using alternative chemistry — typically sulfur donor systems at very low concentrations, or carbamate-free formulations — that achieve the same mechanical performance without leaving sensitizing residue at detectable levels.

(We've been running accelerator-free compound in our in-house lab since the European hospital tender requirements started tightening around 2018. The formulation work took longer than we expected — getting the tensile and elongation numbers to match conventional nitrile without the standard accelerator package required about a year of iteration.)

—

The Standards That Define Compliance — and What They Actually Test

"Accelerator-free" is not a self-certified marketing claim in regulated markets. There are specific test methods and thresholds that determine whether a glove qualifies.

Standard / Test	What It Covers	Threshold / Requirement
EN 455-4	Shelf life and degradation for medical gloves	Framework standard; accelerator-free claims tested under EN ISO 21420 annex
EN ISO 21420:2020 Annex C	Chemical sensitizers in protective gloves	Thiurams, dithiocarbamates, MBT below detection limits
ASTM D6319	Nitrile examination gloves — physical performance	Tensile strength, elongation, AQL — does not address accelerator content
EN 420 (superseded by EN ISO 21420)	General requirements for protective gloves	Predecessor standard; still referenced in some older tenders
German TRGS 401	Occupational skin protection guidance	Recommends accelerator-free gloves for sensitized workers

The test that matters most for European hospital tenders is EN ISO 21420 Annex C. It uses extraction and chromatographic analysis (typically HPLC or GC-MS) to quantify residual accelerator content. A glove that passes has accelerator levels below the method's detection threshold — not just "low," but undetectable by the specified method.

ASTM D6319, which governs the US market, does not include an accelerator content requirement. FDA 510(k) clearance for examination gloves covers physical performance and biocompatibility under ISO 10993, but accelerator-free status is a separate specification layer. US hospital systems that require accelerator-free gloves are typically specifying it as an additional procurement criterion beyond the base FDA clearance.

This distinction matters when you're sourcing for mixed markets. A glove with FDA 510(k) clearance is not automatically EN ISO 21420 Annex C compliant, and vice versa. If your distribution covers both US and European hospital accounts, you need to confirm both documentation sets from your supplier.

—

Where Type IV Allergy Compliance Is Showing Up in Procurement

The shift toward mandatory accelerator-free specification started in Northern and Western Europe. German hospital procurement frameworks began referencing TRGS 401 guidance in tender language around 2015–2017. French public hospital tenders (through the UGAP and regional groupements d'achats) started including accelerator-free as a scored criterion, then as a pass/fail requirement, over the following years. The Netherlands, Scandinavia, and the UK NHS have followed similar trajectories.

The commercial implication for distributors is straightforward: if you're supplying European hospital accounts and your glove line doesn't include an accelerator-free SKU with current EN ISO 21420 Annex C documentation, you're excluded from a growing share of the tender universe. That's not a niche segment — European public hospital procurement represents significant contracted volume, and the contracts run multi-year.

North America is moving more slowly, but the direction is the same. Several large US health systems have added accelerator-free preference language to their GPO specifications. Canadian hospital procurement in Ontario and Quebec has seen similar movement. The driver is occupational health liability: hospitals that document glove-related dermatitis cases among clinical staff face workers' compensation exposure, and switching to accelerator-free is the documented mitigation.

For distributors building a hospital-focused product line, the practical question isn't whether to carry accelerator-free — it's which SKUs, what documentation package, and whether your supplier can hold the spec consistently across reorders.

—

The Specification Details That Separate Compliant Gloves from Marketing Claims

Not every glove labeled "accelerator-free" has the documentation to back it up. Here's what the spec sheet and compliance package should contain for a genuinely compliant product.

Physical performance should meet or exceed standard nitrile examination glove requirements. Accelerator-free formulations that sacrifice tensile strength or elongation to achieve the chemistry are not fit for clinical use. Typical benchmarks for a compliant medical-grade accelerator-free nitrile glove:

Property	Typical Range	Standard Reference
Tensile strength (before aging)	≥ 14 MPa	EN 455-2 / ASTM D6319
Elongation at break (before aging)	≥ 500%	EN 455-2 / ASTM D6319
Thickness (palm, single wall)	0.08–0.12 mm	EN 455-2
AQL	≤ 1.5	EN 455-2 / ISO 2859-1
Accelerator residue	Below detection limit	EN ISO 21420 Annex C

Our accelerator-free line runs at 0.10 mm palm thickness with tensile strength consistently above 16 MPa in pre-shipment testing — the formulation work we did to eliminate the accelerator package didn't require thinning the glove to compensate.

The documentation package for a hospital-grade accelerator-free nitrile glove should include:

• EN 455 Parts 1–4 certificate (current, not expired)
• EN ISO 21420 Annex C test report with actual chromatographic data, not just a pass/fail statement
• FDA 510(k) clearance number (for US market distribution)
• ISO 10993 biocompatibility report if required by the account
• AQL 1.5 inspection records — lot-level, not just type-approval

The Annex C test report is the one most often missing or outdated. Some suppliers provide a certificate of conformity that references EN ISO 21420 without attaching the actual test data. In a hospital tender, that's usually insufficient — procurement teams increasingly require the underlying chromatographic report, not just the declaration.

(We've seen this catch distributors off guard at the tender submission stage. The certificate looks complete until the hospital's technical committee asks for the raw test data and the supplier can't produce it. Request the actual Annex C report, not just the conformity declaration, before you commit to a product line.)

—

What Consistent Supply Actually Requires from the Manufacturer

Passing an accelerator-free test on a type-approval sample is one thing. Holding that specification across 12 months of production orders is another.

The accelerator-free compound is more sensitive to process variation than standard nitrile. The alternative cross-linking chemistry has a narrower processing window — temperature control during dipping and curing matters more, and compound batch consistency is tighter. A manufacturer running accelerator-free on a line that wasn't designed for it will see more lot-to-lot variation in residual chemistry, even if the physical properties stay within spec.

What to look for in a supplier:

• In-house compounding: If the manufacturer buys pre-mixed compound from a third-party supplier, they have limited control over batch-to-batch accelerator content. In-house compounding means the formulation is controlled at the source.
• Dedicated line or validated changeover protocol: Cross-contamination from conventional nitrile production is a real risk. A supplier running accelerator-free on the same line as standard nitrile needs a validated cleaning and changeover procedure, with documentation.
• Lot-level testing, not just type approval: The EN ISO 21420 Annex C type-approval test is done once on a sample. For hospital supply, you want a supplier who runs periodic lot-level verification — either in-house or through a third-party lab — to confirm the production compound hasn't drifted.

We run our accelerator-free compound in our own compounding lab, which means we control the formulation from raw material through finished glove. Our 8 automated dipping lines include dedicated configurations for accelerator-free production, and we run periodic third-party Annex C verification on production lots — not just on the type-approval sample. That documentation is available to distributors as part of the pre-shipment package.

If you're evaluating suppliers for a hospital account that requires accelerator-free, ask specifically: Is your compound mixed in-house or purchased? Do you have lot-level Annex C test data from the past 12 months? The answers tell you more than the certificate.

—

Sourcing Accelerator-Free for Hospital Distribution: The Practical Checklist

When you're building or refreshing a hospital-focused glove line, accelerator-free specification touches several sourcing decisions at once.

SKU selection: Accelerator-free is available in standard examination weight (0.08–0.10 mm) and slightly heavier surgical-adjacent weights. For most hospital examination and procedural use, standard weight is appropriate. If your accounts include surgical or high-risk procedure applications, confirm the thickness and AQL specification matches the clinical requirement.

MOQ and reorder structure: Accelerator-free SKUs typically carry a slightly higher unit cost than standard nitrile — the compound cost is higher and the processing is more controlled. For distributors new to the category, starting with a single-container trial order (approximately 2,000 boxes for standard examination sizes) is a reasonable way to validate the documentation package and physical quality before committing to annual contracted volume.

Private label considerations: If you're building a private-label hospital line, the OEM specification needs to explicitly call out accelerator-free formulation, the EN ISO 21420 Annex C requirement, and the documentation deliverables. Don't assume it's included because the supplier offers accelerator-free as a product line — get it written into the spec sheet and confirmed in the pre-production sample approval.

Documentation timing: Hospital tenders often have tight submission windows. The Annex C test report, EN 455 certificate, and FDA 510(k) documentation need to be current (typically within 3–5 years for type approval, depending on the tender requirements) and available before you submit. Build documentation verification into your supplier qualification process, not your tender preparation process.

For distributors ready to specify or Request Quote on accelerator-free medical nitrile gloves, having the compliance documentation conversation early — before the tender deadline — is the difference between a smooth submission and a last-minute scramble.

—

FAQ: Accelerator-Free Nitrile Gloves for Hospital Procurement

What is the difference between accelerator-free nitrile and latex-free nitrile?

All nitrile gloves are latex-free — nitrile is a synthetic rubber with no natural latex protein. Latex-free addresses Type I latex allergy (IgE-mediated, immediate hypersensitivity). Accelerator-free addresses Type IV contact dermatitis (T-cell-mediated, delayed hypersensitivity) caused by chemical accelerator residues in the glove compound. A glove can be latex-free but still cause Type IV reactions if it contains thiuram or dithiocarbamate accelerators. Hospital procurement that specifies "latex-free" only is not covering the Type IV risk.

Does FDA 510(k) clearance confirm a glove is accelerator-free?

No. FDA 510(k) clearance for examination gloves covers physical performance (tensile, elongation, AQL) and biocompatibility under ISO 10993. It does not test for or certify accelerator content. Accelerator-free status requires separate chemical testing under EN ISO 21420 Annex C or equivalent. For US hospital accounts that require accelerator-free, the specification needs to be confirmed through the supplier's compound documentation and test reports, not inferred from the 510(k) number.

Can a standard nitrile glove line be reformulated to accelerator-free, or does it require a different production setup?

It requires a different compound formulation and, ideally, a controlled production setup. The alternative cross-linking chemistry used in accelerator-free nitrile has a narrower processing window than standard thiuram/dithiocarbamate systems. Manufacturers who simply reduce accelerator concentration rather than eliminating it may still fail EN ISO 21420 Annex C testing. A genuine accelerator-free product requires a reformulated compound and validated production parameters — not just a label change.

How often should accelerator-free certification be renewed for hospital tender purposes?

EN 455 type approval certificates are typically valid for 5 years, but individual hospital tenders may require more recent test data — some specify reports within 3 years, others within 12 months for the Annex C chemical test specifically. Check the tender's documentation requirements before assuming your existing certificates are sufficient. For ongoing supply contracts, ask your supplier about their lot-level verification frequency.

What MOQ is realistic for a first accelerator-free order?

For standard examination sizes (S/M/L in 100-piece boxes), one container — approximately 2,000 boxes — is a workable starting point for distributors entering the hospital segment. This gives you enough volume to validate the documentation package, run your own incoming inspection, and test the product with a pilot account before scaling to annual contracted volume.

French hospital procurement teams are under a specific kind of pressure right now. The post-pandemic normalization of PPE supply has compressed margins across the distribution chain, but the compliance bar hasn't moved — EN 455 remains the non-negotiable entry ticket for any medical-grade nitrile glove entering a French hospital or clinic. What has changed is the sourcing landscape: more distributors, more private-label SKUs, and a wider spread between what a local intermediary charges and what a direct factory relationship costs at volume.

This article maps the current supplier landscape for medical nitrile gloves in France — who the serious players are, what model they operate under, and where the economics shift in favor of factory-direct procurement. If you're screening local suppliers and want to understand the full picture before committing to a framework contract, this is the sourcing intelligence you need.

EN 455 Is the Floor, Not the Differentiator

Before evaluating any supplier, it's worth being precise about what EN 455 actually covers — and what it doesn't. EN 455 is a four-part standard: Part 1 covers freedom from holes (AQL testing), Part 2 covers physical properties (tensile strength, elongation), Part 3 covers biological evaluation (biocompatibility), and Part 4 covers shelf-life determination. A glove carrying the CE mark under EN 455 has passed all four parts.

What EN 455 does not tell you is whether the lot in your current container was manufactured to the same standard as the sample that earned the certificate. Certification is a point-in-time approval. Lot-to-lot consistency is a manufacturing discipline — and that's where supplier evaluation actually starts.

(This distinction matters more than most procurement teams realize. We've seen containers arrive with valid CE documentation where the gloves inside measured 0.06mm at the fingertip — below the physical properties threshold in Part 2. The certificate was real. The production control wasn't.)

The practical implication: when you're evaluating suppliers, ask for the Certificate of Conformity specific to the lot, not just the general CE certificate. Ask for AQL test reports from the production batch, not the type-approval sample. Any serious supplier — local distributor or direct factory — should be able to produce these without hesitation.

How to Evaluate Medical Nitrile Glove Suppliers for French Hospital Supply

The criteria that separate a reliable supply partner from a box-mover are consistent across supplier models. Before you shortlist anyone, run through these:

EN 455 lot-specific documentation — CE certificate plus batch-level CoC and AQL test report. If a supplier can only produce the general type-approval certificate, that's a gap.

Accelerator-free availability — French hospital procurement increasingly specifies accelerator-free (Type IV allergy-compliant) nitrile for clinical staff. Not every supplier stocks it. Confirm whether it's a standard SKU or a special-order item, and whether the formulation has been independently validated.

AQL standard applied — AQL 1.5 is the medical-grade benchmark. Some distributors source to AQL 2.5 and don't advertise the difference. Ask explicitly.

Thickness consistency — Request palm and fingertip measurements from a production sample, not just the nominal spec. A glove listed at 0.10mm that measures 0.07mm at the fingertip is a compliance risk and a durability problem.

Stock depth and replenishment cycle — For framework contracts, you need to know whether the supplier holds 3 months of buffer stock or is running on 2-week replenishment from their own upstream source. The answer changes your emergency procurement exposure.

MOQ and contract flexibility — Local distributors typically offer lower MOQ with shorter lead times. Factory-direct sources offer better unit economics at container scale (typically 2,000–2,500 boxes per 20-foot container) but require forward planning.

Private-label and OEM capability — If you're building a house brand or consolidating SKUs under a single label, confirm whether the supplier can support custom packaging, logo printing, and size-specific box counts. “`

—

Segment 2 — Local landscape (10 companies)

“`markdown

The French and European Medical Nitrile Glove Supply Landscape

The suppliers serving French hospital procurement fall into three distinct models: French-based medical distributors with broad PPE portfolios, pan-European healthcare supply specialists, and European subsidiaries of global glove manufacturers. Understanding which model you're dealing with shapes the conversation around pricing, lead time, and compliance documentation.

Here are ten companies active in the French and broader European medical nitrile glove supply market:

1. Mölnlycke Health Care

Website: molnlycke.com | Model: Global manufacturer / direct supply

Mölnlycke is a Swedish-headquartered manufacturer with a strong French hospital presence, particularly in surgical and examination gloves. Their Biogel and Gammex lines are well-established in French OR procurement. For standard examination nitrile, they operate through a combination of direct hospital contracts and distributor partnerships. Compliance documentation is thorough and lot-traceable. Unit pricing reflects the brand premium — you're paying for the supply chain reliability and the clinical brand recognition, both of which have real value in a hospital setting.

2. Ansell

Website: ansell.com | Model: Global manufacturer / European distribution

Ansell's Micro-Touch and TouchNTuff lines are widely specified in French hospital and laboratory procurement. Their European distribution infrastructure means stock availability is generally reliable for standard SKUs. Ansell holds EN 455 certification across their medical nitrile range and publishes accelerator-free options (their SENSOPRENE line). For high-volume framework contracts, Ansell typically works through appointed distributors rather than direct hospital supply — which adds a margin layer.

3. Sempermed (Semperit Group)

Website: sempermed.com | Model: European manufacturer / direct and distributor

Sempermed is an Austrian-headquartered manufacturer with production in Asia and a European sales infrastructure. Their Supreme Nitrile and Syntegra lines carry EN 455 and are actively sold into French hospital procurement. Sempermed publishes detailed technical data sheets and lot-specific documentation — one of the more transparent suppliers on compliance paperwork in this segment.

4. Unigloves

Website: unigloves.com | Model: European distributor / own-brand manufacturer

Unigloves operates a hybrid model: they source from Asian factories under their own brand and distribute across Europe including France. Their Pearl and Quantum lines are EN 455 certified and competitively priced relative to the major branded manufacturers. Stock is held in European warehouses. For buyers who want a mid-tier price point with solid compliance documentation, Unigloves is a credible option — though lot-to-lot consistency should be verified across multiple orders before committing to a framework contract.

5. Kimberly-Clark Professional (Halyard)

Website: kcprofessional.com | Model: Global manufacturer / European distribution

Kimberly-Clark's Halyard Purple Nitrile line has significant penetration in French hospital procurement, particularly in ICU and high-risk clinical environments. The Purple Nitrile Exam glove carries EN 455 and is available in accelerator-free formulation. Distribution in France runs through appointed medical supply partners. Lead times are generally predictable for standard sizes, though the premium pricing reflects the brand position.

6. Medline Industries (Europe)

Website: medline.com | Model: Large-scale medical distributor / own-brand

Medline operates a broad medical supply distribution model across Europe with a French market presence. Their own-brand nitrile examination gloves are EN 455 certified and positioned as a cost-competitive alternative to branded manufacturers. Medline's scale means stock depth is generally strong for standard SKUs. For hospital procurement teams running high-volume annual contracts, Medline's pricing structure is worth benchmarking against both branded and factory-direct options.

7. Paul Hartmann AG

Website: hartmann.info | Model: European manufacturer / direct hospital supply

Hartmann is a German-headquartered manufacturer with a long-standing presence in French hospital supply, primarily through their wound care and hygiene portfolios. Their Peha-soft nitrile glove line is EN 455 certified and actively specified in French hospital procurement frameworks. Hartmann operates direct sales relationships with major French hospital groups (CHU networks), which gives them a procurement process advantage — but also means pricing is negotiated at the group level rather than per-facility.

8. Rubberex Europe

Website: rubberex.com | Model: Malaysian manufacturer / European distribution

Rubberex is a Malaysian glove manufacturer with European distribution infrastructure. Their medical nitrile range carries EN 455 and CE marking. Rubberex sits in the mid-tier pricing band — below the major European brands, above the lowest-cost Asian commodity suppliers. Their European warehouse stock reduces lead time compared to direct factory import, though the per-unit cost still includes the distribution margin.

9. Supermax Healthcare (Europe)

Website: supermaxhealthcare.com | Model: Malaysian manufacturer / European subsidiary

Supermax operates a European subsidiary that supplies EN 455-certified medical nitrile gloves into the French and broader EU market. Their SuperSafe and Aurelia lines are distributed through medical supply channels. Supermax's scale as a manufacturer (one of the larger Malaysian glove producers) means their compliance documentation infrastructure is well-developed. For buyers who want manufacturer-level documentation without full factory-direct import logistics, Supermax's European entity is a practical middle option.

10. Glovemfg (Qingdao Glovemfg Medical Products Co., Ltd.)

Website: glovemfg.com | Model: Chinese factory-direct manufacturer

We're the factory. We manufacture medical nitrile gloves at our 18,000 m² facility in Qingdao, running 8 fully automated dipping lines at 1.2 billion pieces annual capacity. Our medical nitrile range carries EN 455, CE, ISO 9001:2015, and FDA 510(k) — the full compliance stack for both European and North American hospital procurement. We hold AQL 1.5 as our production standard, not just our sampling standard, with online pinhole detection on every line. Accelerator-free formulation is a standard production option, not a special order. For French hospital procurement teams running framework contracts at container scale, the economics of factory-direct supply are worth a direct comparison.

“`

—

Segment 3 — Cost of convenience, strategic alternative, decision guide

“`markdown

Where Local Distribution Adds Value — and Where It Compresses Margin

Local and European distributors earn their margin in specific scenarios. It's worth being clear about when that margin is justified:

Emergency replenishment — If a ward runs short mid-month, a French or European distributor with local warehouse stock can deliver in 24–72 hours. A factory-direct container takes 25–35 days from order to port. For emergency top-up orders, local supply wins on speed, and the premium is worth paying.

Low-volume or trial orders — Most distributors will supply a single pallet or even a single case. Factory-direct import makes economic sense at container scale (roughly 2,000 boxes minimum for a standard 20-foot container). Below that threshold, the per-unit freight cost erodes the factory price advantage.

Compliance timing — If you're mid-tender and need to demonstrate an approved supply chain immediately, a distributor with existing framework agreements and local stock can satisfy that requirement faster than establishing a new direct factory relationship.

Familiar communication — French-language support, local account management, and invoice processing in euros with standard French payment terms are real operational conveniences that have value in a busy procurement environment.

Where the local model compresses margin is at repeat volume. A distributor buying from a manufacturer at €X and selling to you at €X + 25–40% is a cost that compounds across a full year's consumption. For a hospital group running 500,000–1,000,000 pairs per year, that distribution margin represents a meaningful budget line. At that volume, the question isn't whether factory-direct is cheaper — it almost always is — the question is whether your procurement process can absorb the lead time and container-scale MOQ.

(We've had French healthcare distributors come to us after years of buying from intermediaries. The first container comparison usually shows a 20–30% landed cost reduction. The second conversation is always about how to structure the annual volume to keep buffer stock at their warehouse while ordering direct.)

Factory-Direct Procurement for French Hospital Supply: The Trade-Off Explained

Factory-direct import from a certified manufacturer isn't the right answer for every procurement scenario — but for framework contracts at volume, the economics are straightforward.

Here's how the trade-off actually works for French hospital procurement:

Landed cost — Factory ex-works price + sea freight (Qingdao to Le Havre or Marseille, typically 25–30 days) + customs clearance + local delivery. At container scale, the landed cost per box is consistently below European distributor pricing for equivalent EN 455-certified product. The gap widens for accelerator-free and specialty formulations, where distributor margins are higher.

Compliance documentation — A direct factory relationship gives you full access to lot-specific production records, AQL test reports, raw material certificates, and batch traceability — the documentation stack that hospital accreditation bodies and ANSM (Agence nationale de sécurité du médicament) increasingly expect. Distributors can pass this through, but the chain of custody is longer and documentation requests take more time.

Formulation control — If your hospital group is specifying accelerator-free nitrile for sensitization-sensitive staff, a direct factory relationship lets you lock the formulation at the compound level. We run our accelerator-free compound on dedicated lines — the formulation doesn't change between orders because we control the compounding in-house. A distributor sourcing from multiple factories can't guarantee that level of formulation consistency.

MOQ and planning — The practical entry point for factory-direct is one 20-foot container, approximately 2,000 boxes of standard examination nitrile. For a hospital group or regional procurement consortium, that's typically 4–8 weeks of consumption — manageable with basic forward planning. OEM and private-label runs require a minimum of one container per SKU.

Lead time management — 25–35 days sea transit plus 5–7 days production lead time for in-stock formulations. For custom formulations or new OEM specifications, add 2–3 weeks for compound validation and sample approval. The solution most of our French buyers use is a rolling 90-day order cycle with 30 days of local buffer stock — it eliminates the urgency risk while capturing the cost advantage.

Sourcing Decision Guide: Which Route Fits Your Procurement Scenario

Scenario	Recommended Route	Reasoning
Emergency top-up, < 50 boxes	Local distributor	Speed outweighs cost at this volume
Annual framework, > 500,000 pairs	Factory-direct	Distribution margin compounds significantly at this scale
First-time trial, 1–5 pallets	European distributor or manufacturer subsidiary	Lower commitment, faster qualification
Accelerator-free specification, ongoing	Factory-direct preferred	Formulation consistency requires compound-level control
OEM / private-label program	Factory-direct only	Distributors cannot support custom specification
Tender response, immediate supply needed	Local distributor	Existing framework agreements satisfy tender timelines
Regional consortium procurement	Factory-direct	Volume aggregation makes container economics work

The honest answer is that most serious hospital procurement operations end up running a hybrid: a local distributor relationship for emergency and low-volume needs, and a direct factory relationship for the bulk of annual consumption. The two models aren't mutually exclusive — they serve different parts of the procurement calendar.

Frequently Asked Questions

Does EN 455 certification from a Chinese factory carry the same weight as European manufacturer certification for French hospital procurement?

Yes, provided the certification was issued by a notified body recognized under EU MDR (Medical Device Regulation). EN 455 is a harmonized European standard — the geographic location of the manufacturer is irrelevant to the validity of the certification. What matters is which notified body issued the CE certificate and whether the certificate is current. Chinese manufacturers exporting to Europe routinely use EU-recognized notified bodies (SGS, TÜV, Bureau Veritas) for EN 455 certification. Ask for the notified body number on the CE certificate and verify it against the NANDO database.

What is the difference between AQL 1.5 and AQL 2.5 for medical nitrile gloves, and does it matter for hospital procurement?

AQL 1.5 means the acceptable quality limit for defects is 1.5% — tighter than AQL 2.5. EN 455 Part 1 specifies AQL 1.5 for freedom from holes in medical examination gloves. Some suppliers apply AQL 2.5 at the production level and only tighten to 1.5 for final inspection sampling — which means more defective units pass through production before being caught. For hospital procurement, specify AQL 1.5 as the production standard, not just the final inspection standard, and ask for the production QC records to confirm.

How do I verify that an accelerator-free nitrile glove is genuinely accelerator-free, not just labeled as such?

Request the raw material safety data sheet for the nitrile compound and the independent biocompatibility test report under EN ISO 10993-10 (sensitization testing). A genuine accelerator-free formulation will show no thiurams, dithiocarbamates, or mercaptobenzothiazole derivatives in the compound SDS. The EN ISO 10993-10 report should confirm no sensitization response. Some suppliers label gloves "low-accelerator" or "reduced-accelerator" — that is not the same as accelerator-free. If the documentation doesn't exist or can't be produced, the claim isn't verified.

What documentation should I request before accepting a container of EN 455 medical nitrile gloves?

At minimum: CE certificate with notified body number and current validity date, Certificate of Conformity specific to the production lot, AQL test report for the lot (Part 1 pinhole testing), physical properties test report (Part 2), and the packing list with lot numbers traceable to the test reports. For accelerator-free product, add the compound SDS and EN ISO 10993-10 biocompatibility report. For ANSM-regulated procurement, confirm the manufacturer's EU Authorized Representative is named on the CE certificate.

What is the minimum order for factory-direct medical nitrile gloves from China to France?

For standard EN 455-certified examination nitrile in stock formulations, the practical minimum is one 20-foot container — approximately 2,000 boxes of 100 gloves (200,000 pairs). Below that volume, the per-unit freight cost erodes the factory price advantage. For OEM or private-label specifications, the minimum is typically one container per SKU. Some factories will consolidate multiple SKUs into a single container if the total volume reaches the container minimum — worth asking about if you're running multiple sizes or grades.

Structuring a Factory-Direct Trial for French Hospital Procurement

If you're considering a direct factory relationship for the first time, the lowest-risk entry point is a sample qualification followed by a single trial container. Here's how we typically structure it with new French buyers:

Step 1 — Sample qualification: We ship a sample set (typically 2–3 boxes per size) with the full documentation package: CE certificate, CoC, AQL report, physical properties report, and compound SDS for accelerator-free product. Your QC team evaluates against your internal specification. This takes 7–10 days from sample dispatch.

Step 2 — Trial container: One 20-foot container of your primary SKU. We provide lot-specific documentation before shipment so your compliance team can review before the container arrives. Payment terms for first orders are typically 30% deposit, 70% against bill of lading.

Step 3 — Framework agreement: Once the trial container is received and validated, we can structure a rolling annual supply agreement with fixed pricing, priority production scheduling, and 30-day lead time for repeat orders.

For French hospital procurement teams running annual tenders, we can provide the full compliance documentation package required for tender submission — including EN 455 certificates, ISO 9001:2015 certification, and EU Authorized Representative details — before you commit to any order.

If you're ready to compare specifications and landed cost against your current supplier, request a quote with your annual volume, size breakdown, and whether you need standard or accelerator-free formulation. We'll come back with a detailed landed cost comparison, not just an ex-works price.

For more on our medical nitrile gloves range — including thickness options, formulation variants, and OEM capabilities — the product page covers the full specification. “`

The Canadian medical glove market runs on a small number of large national distributors, a handful of regional players, and an increasingly direct pipeline from overseas manufacturers. If you're sourcing medical nitrile gloves for healthcare distribution in Canada right now, you're navigating all three layers simultaneously — and the pricing gap between them has widened considerably since 2021.

This review covers the main supplier models operating in Canada, what each one is actually good for, and where the economics shift in favor of factory-direct procurement. We've handled pre-shipment documentation and compliance verification for Canadian healthcare distributors for years, so the framing here is practical, not theoretical.

How the Canadian Medical Glove Supply Chain Actually Works

Most Canadian healthcare distributors buy from one of two places: a national distributor who warehouses domestically, or a direct import arrangement with an overseas manufacturer. The middle layer — regional importers who bring in container loads and resell — exists but has thinned out since the pandemic-era supply disruptions reshuffled supplier relationships.

The national distributor model offers real advantages. Stock is on Canadian soil, delivery is measured in days not weeks, and the supplier relationship is straightforward to manage. For urgent replenishment, small top-up orders, or situations where your customer needs product before a regulatory deadline, that local inventory is worth paying for.

The cost of that convenience is real, though. A national distributor is carrying warehousing, logistics, and margin across the chain. By the time medical nitrile gloves reach your invoice, you're typically paying a landed-and-marked-up price that reflects two or three margin layers above the factory gate. For distributors running thin margins on healthcare contracts — especially provincial tender business — that stacked cost structure compresses what you can offer competitively.

The compliance picture in Canada adds another layer. Medical nitrile gloves sold into Canadian healthcare settings need to meet Health Canada's Medical Devices Regulations under the Food and Drugs Act. Class I medical devices (examination gloves) require a Medical Device Establishment Licence (MDEL) for importers and distributors, and the gloves themselves need to meet ASTM D6319 or equivalent performance standards. FDA 510(k) clearance is not automatically recognized in Canada, though it's a useful signal of manufacturing quality. (We see this confusion regularly — buyers assume FDA clearance covers Canadian import requirements. It doesn't, and a container held at the border is an expensive lesson.)

What Separates a Reliable Medical Nitrile Supplier from a Commodity One

Before walking through the supplier landscape, it's worth being clear about what actually matters when you're evaluating a medical nitrile glove supplier for healthcare distribution. The criteria that protect your business are not the same as the criteria that look good in a product brochure.

AQL standard and inspection methodology — Medical examination gloves should be inspected to AQL 1.5 for critical defects. AQL 2.5 is common in industrial glove supply and is not appropriate for medical-grade product. Ask specifically: is AQL 1.5 applied at the production line, or only at final pre-shipment inspection? The answer tells you a lot about how seriously a manufacturer treats defect control.

Pinhole detection — Online pinhole detection systems running during production are the difference between catching a defect before it ships and discovering it after your customer has opened the box. Not every factory runs them. We run 100% online detection on all eight of our dipping lines — it's not optional for medical-grade output.

Compound consistency — Nitrile glove performance depends heavily on the formulation. Factories that buy compound from external suppliers have less control over batch-to-batch consistency than factories running their own compounding lab. Thickness variation is the most common downstream complaint we hear from distributors switching suppliers — a glove that measures 0.10mm at the palm and 0.07mm at the fingertip will fail AQL at destination.

Certification scope — ISO 9001:2015 covers quality management systems. EN 455 covers medical glove performance for European markets. ASTM D6319 is the relevant US/Canadian performance standard for nitrile examination gloves. FDA 510(k) clearance means the device has been reviewed for substantial equivalence. A supplier holding all four has been through meaningful external scrutiny. A supplier holding only ISO 9001 has demonstrated process management, not product performance.

Accelerator-free availability — Canadian hospital procurement increasingly specifies accelerator-free nitrile for sensitization-sensitive environments. If your supplier can't offer a Type IV allergy-compliant formulation from the same facility, you're going to lose tenders as that specification becomes standard.

The 10 Suppliers Operating in the Canadian Medical Nitrile Glove Market

The Canadian market is served by a mix of national healthcare distributors, manufacturer-owned distribution arms, and direct-import manufacturers. Here's an honest look at each.

1. McKesson Canada — mckesson.ca

McKesson is the largest healthcare distributor in Canada by revenue and breadth of product range. Their nitrile glove offering spans multiple brands and grades, with national warehouse coverage that makes them the default choice for hospital systems and large clinic networks. The trade-off is that McKesson is a distributor, not a manufacturer — you're buying through their margin layer, and product-level specification flexibility is limited to what they stock. For distributors who need to differentiate on spec or private label, McKesson is not the right channel.

2. Cardinal Health Canada — cardinalhealth.ca

Cardinal Health operates both distribution and manufacturing arms globally, and their Canadian distribution business covers medical consumables including nitrile examination gloves. Their Flexal and similar branded lines are well-established in Canadian hospital procurement. Like McKesson, Cardinal Health's Canadian operation is primarily a distribution business — the manufacturing leverage is in their US and global operations, not locally. Pricing reflects a full distribution margin.

3. Medline Canada — medline.com

Medline is a US-headquartered manufacturer-distributor that operates in Canada. Their model is closer to direct than pure distribution — they manufacture a significant portion of their own product lines — which gives them more pricing flexibility than pure distributors. Their nitrile glove range covers examination and procedure grades. Canadian healthcare distributors buying Medline are getting a more integrated supply chain than with McKesson or Cardinal, though the product range is still standardized rather than customizable.

4. Henry Schein Canada — henryschein.ca

Henry Schein's Canadian operation is strongest in dental and medical office supply. Their nitrile glove offering is broad but oriented toward smaller-volume buyers — dental practices, clinics, and medical offices rather than hospital systems or large-volume distributors. If your customer base is in that segment, Henry Schein is a relevant benchmark for pricing. For high-volume healthcare distribution, their model is less competitive on unit economics.

5. Ansell — ansell.com

Ansell is a global glove manufacturer with strong brand recognition in both medical and industrial segments. Their GAMMEX and MICRO-TOUCH lines are specified in Canadian hospital procurement. Ansell manufactures in Malaysia and other locations and distributes through Canadian healthcare channels. Their medical nitrile range is well-certified and widely accepted. The limitation for distributors is that Ansell sells branded product — private-label or OEM arrangements are not their model, and pricing reflects a premium brand position.

6. Kimberly-Clark Professional — kcprofessional.com

Kimberly-Clark's Purple Nitrile line has significant penetration in Canadian healthcare settings, particularly in surgical and procedure environments. Like Ansell, they sell branded product through distribution channels. Their Canadian presence is strong, but the model is brand-driven rather than specification-flexible. Distributors carrying KC Professional are selling a recognized brand, which has value in certain procurement contexts, but the margin structure reflects that brand premium.

7. Supermax Healthcare — supermaxglove.com

Supermax is a Malaysian nitrile glove manufacturer with North American distribution infrastructure. They supply both branded and private-label product and have been active in the Canadian market, particularly during and after the pandemic supply disruptions. Their manufacturing scale is significant. For distributors looking for a manufacturer-direct relationship with North American distribution support, Supermax is one of the more accessible options. Certification coverage includes FDA 510(k) and EN 455.

8. Sempermed — sempermed.com

Sempermed is an Austrian glove manufacturer (part of the Semperit Group) with distribution into North American healthcare markets including Canada. Their medical nitrile range is well-regarded in European hospital procurement and carries EN 455 certification. Canadian distribution is handled through healthcare supply channels. Sempermed's positioning is quality-focused rather than price-competitive — they're a reasonable benchmark for premium-tier medical nitrile specification.

9. Cranberry USA — cranberryusa.com

Cranberry is a glove manufacturer supplying the North American dental and medical market with a range that includes nitrile examination gloves. They've built distribution into Canadian dental and medical supply channels. Their product range includes standard and specialty formulations. For distributors serving dental and medical office segments, Cranberry is a relevant supplier to benchmark — their pricing tends to be more competitive than the major branded players.

10. Dynarex — dynarex.com

Dynarex is a US-based medical supply company with a broad consumables range including nitrile examination gloves. Their Canadian distribution covers medical and long-term care segments. Dynarex competes on price and breadth of product range rather than premium specification. For distributors supplying cost-sensitive segments — long-term care, home health, community clinics — Dynarex is a relevant pricing reference point.

Where Local Distribution Adds Real Value — and Where It Doesn't

The suppliers above serve the Canadian market well for specific buying situations. Local distribution is genuinely the right answer when:

• You need product in days, not weeks. A hospital system running low on examination gloves mid-contract doesn't have six weeks for a container. Local stock solves that problem, and the premium is worth paying.
• Your order volume is below container minimums. A 200-case top-up order doesn't justify a direct import arrangement. Local distributors exist precisely for this use case.
• You're in a compliance-sensitive procurement cycle. If your customer needs documentation that references a Canadian-registered supplier, local distribution simplifies that paperwork trail.
• You're new to a product category. Starting with a local distributor while you learn the spec requirements and customer preferences is a reasonable risk management approach before committing to container-scale direct import.

These are real advantages. A sourcing review that dismisses them isn't being honest with you.

The economics shift when your volume grows. At repeat container scale — roughly 2,000 boxes per order and above — the cost structure of buying through a national distributor starts to work against your margin. You're paying for warehousing you don't need, logistics you could manage directly, and a margin layer that doesn't add value at your volume. The question isn't whether local distribution is bad. The question is whether it's the right model for your current order profile.

The Landed Cost Gap at Container Scale

The pricing difference between buying through a Canadian distributor and importing direct from a certified manufacturer is not trivial at volume. We're not going to publish a specific number here because it varies by grade, thickness, and market conditions — but the structural gap is consistent.

A national distributor buying from a manufacturer, warehousing in Canada, and selling to you is running at least two margin layers above the factory gate. At commodity nitrile pricing, that gap can represent 20–35% of your unit cost depending on the grade and the distributor's own cost structure. For a distributor running a healthcare contract at fixed pricing, that gap is the difference between a profitable account and a break-even one.

The calculation changes when you factor in the full landed cost of direct import: ocean freight, customs duties (Canada's MFN tariff on nitrile gloves from most manufacturing countries is relatively low), MDEL compliance costs, and the working capital tied up in a container. For buyers doing this for the first time, those costs are real and need to be modeled carefully. For buyers who have run the numbers and are doing repeat container procurement, the economics are usually clear.

(We've helped Canadian distributors model this comparison more times than I can count. The tipping point is almost always around the third or fourth container — by then the process is familiar, the documentation is templated, and the per-unit savings are compounding.)

Factory-Direct as a Structural Sourcing Decision for Medical Nitrile Gloves

Factory-direct import from a certified manufacturer is not a workaround for buyers who can't get local supply. It's a deliberate sourcing decision that makes sense when your volume, margin requirements, and compliance capability align.

At glovemfg, we manufacture medical nitrile gloves across examination and procedure grades from our 18,000 m² facility in Qingdao. Eight fully automated dipping lines run at a combined annual capacity of 1.2 billion pieces. That scale means your container order — typically 2,000 boxes for a standard 20-foot container — doesn't compete with other buyers for line time. We've been running since 2007, and the facility and team are built around consistent output at export quality, not sample-quality production.

The certifications that matter for Canadian healthcare distribution are in place: ISO 9001:2015, CE, EN 455, ASTM D6319, and FDA 510(k). For buyers navigating Health Canada's MDEL requirements, we can provide the technical documentation package — test reports, lot traceability records, and certificate of conformance — that your compliance team needs.

Our in-house compounding lab is the part of our operation that most directly affects what you receive. We formulate our own nitrile compound rather than buying from external suppliers, which gives us control over batch-to-batch consistency that contract manufacturers using third-party compound can't match. The 0.08–0.15mm thickness tolerance we hold across production runs is a function of that compound control combined with our automated dipping line calibration. Thickness variation is the most common quality complaint we hear from distributors who've switched to us from other suppliers — and it's the first thing we address in our pre-shipment AQL 1.5 inspection.

For Canadian distributors who need accelerator-free nitrile — increasingly specified in hospital and long-term care procurement — we produce Type IV allergy-compliant formulations from the same facility. This isn't a separate product line requiring a separate supplier relationship. It's a formulation variant we can run on the same lines with the same QC standards.

OEM and private-label arrangements are available from a minimum of one container (approximately 2,000 boxes) for standard SKUs. Custom formulations, thickness specifications, and branded packaging are supported with standard lead times. If you're building a private-label medical glove line for the Canadian market, the compliance documentation and OEM specification process is something we've done with Canadian buyers before — it's not a new workflow for us.

Matching Your Sourcing Model to Your Order Profile

The right sourcing decision depends on where you are in your procurement cycle and what your volume looks like. Here's a straightforward framework:

Use local distribution when:

• Order volume is below one container (under ~2,000 boxes)
• Delivery urgency is under two weeks
• You're in a compliance transition and need domestic documentation support
• You're testing a new grade or specification before committing to volume

Consider factory-direct when:

• You're running repeat orders of one container or more
• Your margin on healthcare contracts is under pressure from local pricing
• You need private-label or custom specification that local distributors can't provide
• You're building a product line and need consistent spec across multiple orders

The hybrid model most of our Canadian buyers land on: local distributor for emergency top-ups and small orders, factory-direct for planned procurement cycles. The two models aren't mutually exclusive — they serve different parts of your inventory management problem.

The suppliers listed in this review are real businesses serving the Canadian market. For standard-grade examination gloves at distributor-friendly pricing, McKesson, Cardinal Health, and Medline are the most accessible starting points. For branded product with strong hospital specification acceptance, Ansell and Kimberly-Clark are the benchmarks. For manufacturer-direct relationships with more pricing flexibility, Supermax and Cranberry are worth evaluating alongside a factory-direct option.

What none of the distributor-model suppliers can offer is the combination of custom formulation, private-label OEM, and direct factory pricing at container scale. That's where the economics of a direct manufacturing relationship become relevant to your business.

Frequently Asked Questions

What certifications do medical nitrile gloves need for Canadian healthcare distribution?

Gloves sold as medical devices in Canada must comply with Health Canada's Medical Devices Regulations. Importers and distributors need a Medical Device Establishment Licence (MDEL). The gloves themselves should meet ASTM D6319 (the standard for nitrile examination gloves) or equivalent performance standards. FDA 510(k) clearance is a useful quality signal but does not substitute for Canadian regulatory compliance. EN 455 certification, while a European standard, is widely accepted as evidence of medical-grade performance in Canadian procurement.

What is AQL 1.5 and why does it matter for medical gloves?

AQL (Acceptable Quality Level) 1.5 means that in a statistically sampled inspection, no more than 1.5% of units in a lot may contain critical defects. For medical examination gloves, AQL 1.5 is the appropriate standard — it's more stringent than AQL 2.5, which is common in industrial glove supply. When evaluating a supplier, ask whether AQL 1.5 is applied at the production line or only at final pre-shipment inspection. Production-line inspection catches defects before they compound across a batch.

What is the minimum order for factory-direct medical nitrile gloves from China?

For standard SKUs, one 20-foot container — approximately 2,000 boxes of 100 gloves — is a workable minimum for most manufacturers including glovemfg. Below that volume, the logistics economics don't favor direct import. For OEM or custom-specification orders, MOQ may be higher depending on the formulation and packaging requirements. Most Canadian distributors doing factory-direct procurement run at one to three containers per order cycle.

Are accelerator-free nitrile gloves available from factory-direct suppliers?

Yes. Accelerator-free nitrile — formulated without thiurams, carbamates, and mercaptobenzothiazole accelerators — is available from manufacturers running their own compounding labs. It's not a separate product category requiring a different supplier; it's a formulation variant. For Canadian hospital and long-term care procurement where Type IV allergy sensitivity is a specification requirement, confirm that your supplier can provide the relevant test documentation demonstrating accelerator-free compound, not just a label claim.

How do I verify a medical nitrile glove supplier's certifications before placing a container order?

Request the actual certificate documents, not just a list of certifications. For FDA 510(k), the clearance number is publicly searchable in the FDA's 510(k) database — verify it matches the specific product and manufacturer. For EN 455, the certificate should name the notified body that issued it and include an expiry date. For ISO 9001:2015, the certificate should name the certification body and the scope of certification. Pre-shipment, request the lot-specific test report and certificate of conformance for your order — these should reference the specific production lot, not just the product line.

—

If your current sourcing model is under margin pressure or you're evaluating a private-label medical nitrile line for the Canadian market, the comparison between local distribution and factory-direct procurement is worth running with real numbers. We can provide a landed-cost comparison for your specific grade, volume, and delivery requirements — Request Quote with your target specification and we'll put together a detailed breakdown.

For more on our medical nitrile glove range and available grades, visit our Medical Nitrile Gloves category page.

“`

Most container-level sourcing problems with medical nitrile gloves don't start at the factory. They start at the specification stage, when a buyer assumes that "FDA-cleared" or "EN 455 certified" on a product sheet means the lot in their container was made to the same standard as the sample that earned the clearance. It often wasn't.

This guide walks through what FDA 510(k), EN 455, and AQL 1.5 actually require — and what they don't cover — so you can ask the right questions before you commit to a supplier, not after a container arrives at your warehouse with a compliance problem.

—

What FDA 510(k) Clearance Actually Covers — and What It Doesn't

FDA 510(k) clearance means the glove design and manufacturing process were reviewed and found substantially equivalent to a legally marketed predicate device. That review happens once, at the time of submission. It does not mean every production lot is tested by the FDA. It does not mean the factory's current output matches the cleared specification.

What 510(k) clearance tells you:

• The glove design (material, thickness range, intended use) was reviewed and accepted
• The manufacturer's quality system was evaluated at the time of clearance
• The product is legally marketable as a medical device in the US under that 510(k) number

What it doesn't tell you:

• Whether the current production lot meets the cleared thickness and physical property specs
• Whether the factory has changed its nitrile compound formulation since clearance
• Whether the AQL inspection standard applied to your specific shipment matches what was declared in the 510(k)

The 510(k) number is a starting point for verification, not a substitute for it. When we handle documentation for US distributors, the first thing we pull is the 510(k) summary — specifically the predicate device comparison and the performance testing data. If a supplier can't produce that summary on request, that's a flag worth taking seriously.

(We've seen cases where a factory holds a valid 510(k) but has since reformulated their compound to reduce cost. The clearance number stays the same. The glove doesn't.)

For medical nitrile gloves destined for US healthcare distribution, the 510(k) number should be verifiable on the FDA's 510(k) database. Cross-reference the applicant name, device description, and clearance date before accepting a product sheet at face value.

—

EN 455: Four Parts, One Standard — and Why Part 3 Is the One Buyers Miss

EN 455 is the European standard for single-use medical examination gloves. It has four parts, and most product sheets only mention the standard by name without specifying which parts were tested. That matters because each part covers a different performance dimension.

EN 455 Part	What It Tests	Why It Matters for Your Order
Part 1	Freedom from holes (AQL leak test)	Barrier integrity — the baseline
Part 2	Physical properties (tensile strength, elongation, thickness)	Durability under clinical use conditions
Part 3	Biological evaluation (biocompatibility, residual chemicals)	Accelerator content, protein levels, extractable chemicals
Part 4	Shelf life determination	Packaging integrity and aging stability

Part 3 is where most sourcing problems hide. It covers residual chemical levels — including thiuram and carbamate accelerators, which are the primary drivers of Type IV allergic contact dermatitis in healthcare workers. European hospital procurement increasingly requires accelerator-free gloves specifically because of EN 455-3 compliance pressure.

If you're supplying into European healthcare accounts or US hospital systems with sensitization policies, "EN 455 certified" on a spec sheet is not enough. You need the EN 455-3 test report, and you need to confirm whether the glove is accelerator-free or accelerator-reduced. Those are different things. Accelerator-reduced gloves still contain thiurams and carbamates — just at lower concentrations. Accelerator-free means the compound was formulated without them from the start.

We run an in-house compounding lab specifically because accelerator-free formulation requires control at the compound level, not just at the finished-glove testing stage. You can't remove accelerators from a standard compound after the fact — the chemistry doesn't work that way. The formulation decision happens before the dipping line runs.

—

AQL 1.5: What the Number Means and How It Gets Misapplied

AQL stands for Acceptable Quality Limit. AQL 1.5 for medical examination gloves means that in a statistically valid sample from a production lot, no more than 1.5% of units may be defective — specifically, no more than 1.5 pinholes per 100 gloves tested under the EN 455-1 or ASTM D6319 water-leak test protocol.

The number sounds tight. In practice, the rigor depends entirely on the sample size used and whether the inspection was performed on the production lot you're actually receiving.

Here's where buyers get caught:

Sample size matters. AQL 1.5 at inspection level II (the standard for medical devices under ISO 2859-1) requires a much larger sample than AQL 1.5 at inspection level I. A supplier can claim AQL 1.5 compliance while using a reduced sample size that statistically allows more defects through. Ask for the inspection level, not just the AQL number.

Pre-shipment vs. in-line inspection. AQL inspection can be performed in-line during production or as a pre-shipment check on finished goods. In-line inspection catches defects earlier and allows for lot rejection before packaging. Pre-shipment inspection on a finished lot is better than nothing, but it's a lagging indicator. We run online pinhole detection on all 8 dipping lines — every glove passes through the detection system before it reaches the packaging stage, not after.

Third-party vs. factory-issued CoA. A Certificate of Analysis issued by the factory is not the same as a third-party inspection report. For container-scale orders, a pre-shipment inspection by SGS, Bureau Veritas, or an equivalent third party gives you independent verification of the AQL result. Factory CoAs are useful for lot traceability, but they don't replace independent inspection for high-stakes shipments.

(The most common complaint we hear from buyers who've had problems with previous suppliers isn't that the gloves failed — it's that the CoA said they passed and the gloves still failed at destination. That gap almost always traces back to sample size or inspection timing.)

—

Thickness, Tensile Strength, and the Specs That Actually Predict Field Performance

Medical nitrile gloves for examination use typically run 0.08–0.12mm at the palm, with fingertip thickness slightly higher due to the dipping geometry. ASTM D6319 and EN 455-2 both set minimum tensile strength and elongation requirements, but the minimums are floors, not targets.

Property	ASTM D6319 Minimum	EN 455-2 Minimum	Practical Range for Medical Use
Thickness (palm)	0.05mm	Not specified	0.08–0.12mm
Tensile strength (before aging)	14 MPa	6 N/cm²	18–24 MPa typical
Elongation at break (before aging)	500%	500%	550–650% typical
Tensile strength (after aging)	14 MPa	6 N/cm²	Should retain >80% of pre-aging value

The aging test is the one that separates well-formulated compounds from cost-cut ones. Accelerated aging simulates shelf life — a glove that meets tensile minimums fresh but drops below spec after aging has a compound stability problem. That problem shows up at the end of the supply chain, when your customer opens a box from the back of their storage room.

We hold our compound formulation to 0.08–0.15mm thickness tolerance across the palm and fingertip zones. That tolerance is tighter than the ASTM minimum because thickness variation is the primary driver of AQL failures at destination — a glove that measures 0.10mm at the palm and 0.07mm at the fingertip will fail the water-leak test at the thin point, not the average.

Textured fingertip variants add a surface profile that affects grip under wet conditions. The texture is formed during the dipping process by controlling the coagulant application — it's not a post-process treatment. That matters because post-process texturing can create micro-tears in the film that compromise barrier integrity. If a supplier offers textured gloves, ask whether the texture is formed in-line or applied after dipping.

—

The Documentation You Should Request Before a Container Ships

Compliance documentation for medical nitrile gloves falls into two categories: device-level certification (issued once, covers the product design) and lot-level documentation (issued per production run, covers the specific goods in your container).

Most sourcing disputes trace back to buyers who verified device-level certification but didn't request lot-level documentation before payment.

Device-level documents to verify:

• FDA 510(k) clearance letter and summary (verify on FDA database)
• EN 455 Parts 1–4 test reports (issued by a notified body, not self-declared)
• ISO 9001:2015 certificate (verify issuing body and expiry date)
• ASTM D6319 test report if US market is the destination

Lot-level documents to request per shipment:

• Certificate of Analysis (CoA) with lot number, production date, AQL result, and inspection level
• Pre-shipment inspection report (third-party preferred for container-scale orders)
• Packing list with box count, glove count per box, and lot traceability
• For accelerator-free claims: EN 455-3 test report specific to the compound batch

One thing we do that most factories don't: we maintain lot traceability back to the compound batch. If a quality issue surfaces after delivery, we can pull the compound batch record, the in-line inspection data, and the pre-shipment CoA for that specific lot. That traceability is what makes a quality claim resolvable instead of a dispute.

If a supplier can't provide lot-level documentation before shipment, that's not a paperwork problem — it's a quality system problem.

—

Powder-Free, Accelerator-Free, and Latex-Free: Three Claims That Mean Different Things

These three terms appear together on product sheets often enough that buyers sometimes treat them as interchangeable. They're not.

Powder-free means the glove was manufactured without cornstarch or other powder lubricants. This is now the standard for medical examination gloves — powdered gloves were banned by the FDA for most medical uses in 2017. If a supplier is still offering powdered medical examination gloves for US distribution, that's a compliance problem, not a product option.

Latex-free means the glove contains no natural rubber latex. Nitrile gloves are inherently latex-free — nitrile is a synthetic rubber. The claim is accurate but redundant for nitrile. Where it matters is in documentation for hospital procurement systems that require explicit latex-free certification for allergy management protocols.

Accelerator-free is the claim that requires the most scrutiny. Nitrile gloves are vulcanized using chemical accelerators — typically thiurams, carbamates, or mercaptobenzothiazole compounds. These accelerators can remain as residuals in the finished glove and are the primary cause of Type IV contact dermatitis in healthcare workers. Accelerator-free formulation means the compound was developed using an alternative vulcanization chemistry that eliminates these residuals.

Not all suppliers who claim "accelerator-free" have actually reformulated their compound. Some reduce accelerator levels and call the result accelerator-free. The EN 455-3 test report is the verification document — it will show residual chemical levels. If a supplier claims accelerator-free but can't produce an EN 455-3 report with extractable chemical data, the claim is unverified.

We developed our accelerator-free compound in-house through our compounding lab. The formulation took longer to stabilize than a standard compound — alternative vulcanization chemistry affects cure time and tensile properties, and getting both right without accelerators required iteration. The EN 455-3 data is available for any buyer evaluating our accelerator-free SKU.

—

Sourcing at Container Scale: MOQ, Lead Time, and What "OEM" Actually Involves

For US healthcare distributors sourcing at container scale, the practical sourcing questions come down to minimum order quantities, lead time reliability, and what private-label OEM actually requires in terms of specification and documentation.

Our standard MOQ is one container — approximately 2,000 boxes for standard examination glove SKUs. That's roughly 200,000 pairs depending on box count configuration. For buyers new to direct factory sourcing, one container is a workable trial volume that lets you verify quality and documentation before committing to annual volume agreements.

OEM private-label for medical nitrile gloves involves more than printing your brand on the box. For US distribution, your private-label product needs to be covered by a 510(k) clearance — either your own or the manufacturer's, depending on your regulatory strategy. If you're using the manufacturer's 510(k), you need to confirm that your label configuration is covered under that clearance. If you're building toward your own 510(k), the manufacturer needs to be named in your quality agreement and capable of providing the manufacturing documentation the FDA requires.

(This is where a lot of first-time private-label buyers get surprised. The 510(k) question comes up at customs, not at the factory. Better to resolve it before the container ships.)

We support both paths — supplying under our existing FDA 510(k) for distributors who want to move quickly, and providing full manufacturing documentation for buyers building their own regulatory submissions. The documentation package for the latter includes compound batch records, in-process inspection data, and finished product test reports by lot.

For buyers evaluating us against other suppliers, the question worth asking any factory is: can you provide lot-level traceability documentation for the last three shipments you made to a US healthcare distributor? The answer tells you more about their quality system than any certification list.

—

Common Sourcing Mistakes That Show Up After the Container Arrives

These aren't hypothetical. They're the patterns we see when buyers come to us after a problem with a previous supplier.

Accepting a sample that doesn't represent production. Samples are often made on a dedicated run with tighter QC than standard production. The sample passes every test. The container doesn't. The fix is to request a pre-shipment inspection on the actual production lot, not just the sample.

Verifying the 510(k) number without checking the device description. A 510(k) number can be valid but cover a different glove configuration than what you're ordering. Check that the cleared device description matches the product you're buying — material, thickness range, intended use.

Treating AQL 1.5 as a pass/fail binary. AQL 1.5 is a statistical sampling standard. A lot that "passes" AQL 1.5 can still contain defective units — the standard defines an acceptable defect rate, not zero defects. For high-sensitivity applications, ask about the inspection level and sample size used.

Not specifying size distribution in the purchase order. Medical examination gloves are ordered in size runs — typically S/M/L/XL. If your PO doesn't specify the size distribution, the factory will ship the distribution that's most efficient for their production schedule, which may not match your market demand.

Assuming EN 455 certification covers the US market. EN 455 is a European standard. It's relevant for European distribution and useful as a quality benchmark, but it doesn't substitute for FDA 510(k) clearance for US medical device distribution. Both are needed if you're supplying into both markets.

—

Evaluating a Medical Nitrile Glove Supplier: A Practical Checklist

Before committing to a container-scale order, these are the verification points worth working through systematically.

Regulatory documentation:

• [ ] FDA 510(k) number verified on FDA database, device description matches product
• [ ] EN 455 Parts 1–4 test reports available (notified body issued, not self-declared)
• [ ] ISO 9001:2015 certificate current and issuing body verifiable
• [ ] ASTM D6319 test report available for US-destined product

Lot-level quality:

• [ ] CoA format includes lot number, production date, AQL result, and inspection level
• [ ] Pre-shipment inspection by third party available or arrangeable
• [ ] Lot traceability to compound batch confirmed

Product specification:

• [ ] Thickness range specified and confirmed against 510(k) cleared range
• [ ] Accelerator-free claim supported by EN 455-3 extractable chemical data (if applicable)
• [ ] Powder-free confirmed (required for US medical use)
• [ ] Textured fingertip: in-line formation confirmed (not post-process)

OEM/private-label (if applicable):

• [ ] 510(k) coverage for your label configuration confirmed
• [ ] Quality agreement in place naming manufacturer
• [ ] Manufacturing documentation package scope agreed before order placement

—

FAQ: Medical Nitrile Glove Procurement for US Healthcare Distribution

What is the difference between FDA 510(k) clearance and FDA registration for nitrile gloves?

FDA registration means the manufacturing facility is registered with the FDA as a medical device manufacturer — it's a facility-level requirement. FDA 510(k) clearance is a product-level authorization that allows a specific glove design to be marketed as a medical device in the US. Both are required for legal US medical device distribution. A factory can be FDA-registered without having 510(k) clearance for a specific product, and a 510(k) clearance doesn't automatically mean the manufacturing facility is currently registered. Verify both independently.

Can I use EN 455-certified gloves for US hospital distribution without FDA 510(k) clearance?

No. EN 455 is a European standard and does not satisfy FDA requirements for medical device marketing in the US. Gloves sold as medical examination gloves in the US must have FDA 510(k) clearance. EN 455 certification is useful as a quality benchmark and required for European distribution, but it's not a substitute for 510(k) clearance in the US market.

What AQL level should I specify for medical examination gloves?

AQL 1.5 is the standard for medical examination gloves under both EN 455-1 and ASTM D6319. Some hospital procurement specifications require AQL 1.0 for higher-risk applications. When specifying AQL, also specify the inspection level (Level II is standard for medical devices under ISO 2859-1) and whether you require third-party pre-shipment inspection. AQL level alone, without inspection level and sample size, is an incomplete specification.

How do I verify that a supplier's accelerator-free claim is genuine?

Request the EN 455-3 test report for the specific compound batch used in your order. The report should show extractable chemical levels for thiurams, carbamates, and mercaptobenzothiazole compounds. A genuine accelerator-free glove will show non-detectable or negligible levels of these compounds. If the supplier can only provide a general product certification rather than a compound-specific test report, the claim is unverified for your specific lot.

What is a reasonable MOQ for a first container order of private-label medical nitrile gloves?

One container (approximately 2,000 boxes for standard examination gloves) is a workable first order for most distributors. Below that volume, the economics of private-label setup — label artwork, regulatory documentation, box configuration — typically don't justify the per-unit cost. For buyers new to direct factory sourcing, a single-container trial order with full pre-shipment inspection is a lower-risk way to verify quality and documentation before committing to annual volume.

What documents should I request before a container of medical nitrile gloves ships?

At minimum: the Certificate of Analysis for the production lot (with lot number, AQL result, and inspection level), the packing list with lot traceability, and confirmation that the 510(k) clearance covers the specific product configuration in your order. For container-scale orders, a third-party pre-shipment inspection report from SGS, Bureau Veritas, or equivalent adds independent verification. For accelerator-free products, the EN 455-3 test report for the compound batch used in your order.

—

If you're evaluating suppliers for a container-scale order of medical nitrile gloves and want to work through the specification and documentation requirements before committing, we're straightforward to work with. Send your grade requirements, size distribution, and destination market to our team and we'll put together a detailed quote with the full documentation package — Request a Quote.

Most US distributors who contact us about private label have already done some research. They know they want their brand on the box. What slows them down — sometimes by months — is not finding a factory. It's figuring out what they actually own in a private label arrangement, what compliance documentation they need to hold, and whether the factory they're talking to can deliver consistent product across a full year of orders, not just a sample shipment.

This article covers the mechanics: what private label medical nitrile gloves actually involve, how OEM and ODM differ in practice, what MOQ looks like at container scale, and what the FDA 510(k) and ASTM D6319 compliance picture means for your branded resale program.

What You Own in a Private Label Arrangement — and What the Factory Owns

The confusion here is common and worth clearing up before anything else.

In a private label medical nitrile glove program, you own the brand, the packaging design, and the commercial spec sheet that carries your name. The factory owns the formulation, the production process, and the underlying certifications. You're not buying a formula — you're buying consistent, certified production output that you can brand and resell.

This matters practically because it shapes what documentation you hold and what you reference. Your FDA 510(k) compliance for branded resale doesn't require you to obtain a separate clearance for your label — it requires you to reference the factory's existing 510(k) clearance number in your product documentation and ensure the gloves you're selling were manufactured under that cleared specification. The factory's clearance covers the device; your brand is the commercial layer on top.

What you should lock down in writing before the first container ships:

• Spec sheet under your brand name — thickness range (e.g., 0.08–0.10mm palm, 0.10–0.12mm finger), color, powder-free status, accelerator-free or standard compound, AQL standard, box count (typically 100 or 200 gloves per box)
• Packaging artwork approval — carton label, inner box design, language requirements for US market (English, bilingual if required)
• Certification reference documentation — factory's FDA 510(k) clearance number, ASTM D6319 test report for the specific SKU, ISO 9001 certificate
• AQL documentation — outgoing inspection report per lot, confirming AQL 1.5 or the agreed standard

The spec sheet is the document that protects you. If a container arrives and the gloves don't match the agreed thickness or fail AQL at your warehouse, the spec sheet is what you use to hold the factory accountable. Get it drafted and signed before production starts, not after.

OEM vs ODM: Which Scope Fits Your Program

These two terms get used interchangeably in glove sourcing, but they describe different scopes of work — and the distinction affects your MOQ, your lead time, and how much formulation control you actually have.

OEM (Original Equipment Manufacturer): You're ordering to the factory's existing, validated formulation and spec. The factory has a standard powder-free nitrile examination glove — say, 0.10mm palm thickness, blue, 100-count box — and you're putting your brand on it. The formulation is theirs, the production process is theirs, the certifications are theirs. Your contribution is the brand, the packaging design, and the commercial spec sheet that references their underlying product.

This is the faster, lower-MOQ path. For standard SKUs, MOQ at our facility starts at one 40HQ container — approximately 2,000 boxes for standard examination glove configurations. You're not paying for formulation development or line validation because the product already exists.

ODM (Original Design Manufacturer): You're specifying something that requires formulation or process development — a custom color that isn't in the standard rotation, a specific elongation-at-break target, an accelerator-free compound for a sensitization-sensitive market, or a non-standard thickness profile. The factory develops or adapts the formulation to your spec, validates it, and produces under your brand.

ODM takes longer and typically carries a higher MOQ because the development work has to be amortized across the production run. At our facility, custom formulation ODM projects start at the same one-container minimum, but the timeline includes a formulation development and sample approval phase before production begins. (For accelerator-free compound specifically, we run that on a dedicated line — it's not a special request that requires setting up a new process from scratch, which keeps the lead time reasonable.)

The practical question for most US distributors entering private label: start OEM unless you have a specific market requirement that the factory's standard SKU can't meet. Get a container moving, test it with your customers, and develop a custom formulation in parallel if the market justifies it.

MOQ for Private Label Medical Nitrile Gloves: What the Numbers Actually Mean

MOQ is one of the two questions that stall most private label conversations (compliance is the other). The numbers are straightforward once you understand what drives them.

For standard OEM private label at our facility: one 40HQ container, approximately 2,000 boxes for standard examination glove SKUs (100 gloves per box, 10 boxes per carton). That's roughly 200,000 gloves per container. At that volume, the economics of private label packaging — custom inner box printing, carton labeling, spec sheet production — are absorbed without significantly affecting your per-box cost.

A few things that affect where your actual MOQ lands:

• Size run split: If you're ordering a full size run (XS through XL) in a single container, each size gets a proportionally smaller allocation. We can work with that, but it's worth discussing the split before finalizing the order — some sizes move faster than others, and an unbalanced split can leave you with slow-moving inventory in one size.
• Custom packaging vs. standard: Standard box dimensions and carton configurations are already optimized for 40HQ loading. Custom box sizes can affect carton count per container and therefore your effective MOQ.
• Accelerator-free compound: Same MOQ as standard — one container. We run accelerator-free on a dedicated line, so there's no minimum uplift for the compound itself.
• Custom color: Colors outside the standard rotation (blue, white, black) require a minimum batch for the compound mix. In practice, this usually aligns with the one-container MOQ anyway, but confirm before committing to a color.

Below one container, private label packaging economics don't work — the per-box cost of custom printing on a sub-container run makes the program uncompetitive. If you're testing the market before committing to a full container, the right approach is to order a standard SKU sample (we ship samples within 5–7 business days) and use that to validate demand before the private label investment.

FDA 510(k) and ASTM D6319 Compliance: What US Distributors Actually Need to Hold

This is where a lot of private label programs run into trouble — not because the compliance requirements are complicated, but because distributors don't always know which documents they need to hold versus which ones the factory holds on their behalf.

FDA 510(k) clearance is a device clearance, not a brand clearance. The factory obtains 510(k) clearance for a specific device — in this case, a nitrile examination glove meeting a defined specification. When you sell that glove under your brand, you're selling a device that was manufactured under the factory's cleared specification. You reference the factory's 510(k) clearance number in your product documentation; you don't obtain a separate clearance for your label.

What this means practically: your branded product documentation — spec sheet, product insert, website listing — should reference the factory's FDA 510(k) clearance number. If a US hospital or distributor asks for your FDA documentation, you provide the factory's clearance certificate plus confirmation that your product was manufactured under that cleared specification. The factory should be able to provide a letter of authorization confirming that your branded SKU is covered by their clearance.

(This is the part that trips up first-time private label buyers most often. The FDA clearance question sounds like it requires you to do something — it mostly requires you to document what the factory already has.)

ASTM D6319 is the standard specification for nitrile examination gloves for medical application. It covers physical dimensions, tensile strength, elongation before and after aging, and freedom from holes (AQL). For US market resale, your product documentation should include the factory's ASTM D6319 test report for the specific SKU you're selling — not a generic certificate, but a test report showing the actual measured values for the lot or production run.

The documents you should hold for each private label SKU:

Document	Who Holds It	What It Covers
FDA 510(k) clearance certificate	Factory (you reference it)	Device clearance for the glove specification
Letter of authorization	Factory issues, you hold	Confirms your branded SKU is covered by their 510(k)
ASTM D6319 test report	Factory issues per lot	Physical performance data for the specific production run
ISO 9001:2015 certificate	Factory	Quality management system certification
AQL 1.5 outgoing inspection report	Factory issues per shipment	Lot-level defect rate documentation
CE declaration of conformity	Factory (if selling into EU)	EN 455 compliance for European market

The AQL documentation is worth a specific note. AQL 1.5 is a tighter standard than the AQL 2.5 that many factories use as their default outgoing inspection. The difference: at AQL 1.5, the acceptable defect rate per lot is lower, which means fewer defective units reach your warehouse. When you're building a private label brand, your downstream customers don't know or care about your factory's QC standard — they just know whether the gloves they received are acceptable. AQL 1.5 is the standard that protects your brand reputation at the distribution level.

For a deeper look at how to verify these certifications before a container ships, see our guide on how to verify medical nitrile glove certifications.

Spec Parameters to Lock Before Your First Container

The spec sheet is a contract. Vague specs produce variable product. These are the parameters worth locking explicitly — not because factories will deliberately deviate, but because "standard" means different things to different production teams.

Thickness: Specify palm, finger, and cuff thickness separately, with tolerances. A typical medical examination glove runs 0.08–0.10mm at the palm and 0.10–0.12mm at the finger. Our automated lines hold ±0.01mm tolerance across a production run — but that only matters if the target is written into the spec sheet. "Standard thickness" is not a spec.

Color: Blue, white, and black are standard rotation colors at our facility — no minimum uplift, no development lead time. Custom colors require a Pantone reference and a minimum batch for compound mixing. Confirm before committing.

Compound type: Standard nitrile (accelerator-based vulcanization) or accelerator-free. If you're targeting hospital procurement, dental networks, or any buyer with Type IV allergy sensitivity requirements, accelerator-free is the specification that opens those accounts. Standard compound is fine for general medical, industrial, and food-contact distribution.

Box count: 100 gloves per box is standard for examination gloves. 200-count boxes exist for high-volume clinical settings. The box count affects your per-unit pricing, your carton configuration, and your end-customer's purchasing math — worth specifying explicitly.

Carton labeling format: US market cartons need English-language labeling with lot number, expiry date, and manufacturer information. If you're selling into Amazon FBA or a specific distributor DC, confirm their labeling requirements before artwork approval — some DCs have specific barcode placement and carton dimension requirements that affect how we configure the pack.

Textured fingertip vs. smooth: Textured fingertip improves grip in wet conditions and is standard for most medical examination applications. Smooth finish is available for specific applications. Specify which you need — don't assume.

Red Flags When Evaluating a Private Label Factory

We've had buyers come to us after a failed private label program with another factory. The failure patterns are consistent enough that they're worth naming.

Third-party compounding. If the factory buys pre-mixed nitrile compound from a supplier rather than mixing in-house, they don't control the most important variable in glove consistency. Batch-to-batch variation in the compound translates directly into thickness variation and AQL variance across your orders. Ask specifically: do you mix your own compound? If the answer is vague, that's your answer.

AQL 2.5 as the default standard. Many factories use AQL 2.5 for outgoing inspection. That's an acceptable standard for some applications, but for medical examination gloves going into US healthcare distribution, AQL 1.5 is the standard that keeps your downstream customers from filing complaints. If a factory quotes AQL 2.5 and treats AQL 1.5 as an upgrade tier with a price premium, that tells you something about how they think about quality.

No in-house QC documentation. A factory that can't produce lot-level inspection reports — actual measured values, not just a pass/fail certificate — is a factory that isn't running systematic QC. For private label, you need lot-level documentation because your customers will ask for it, and because it's the only way to trace a quality issue back to a specific production run.

Certifications that don't match the SKU. FDA 510(k) clearance is issued for a specific device specification. If the factory's clearance covers a different thickness range or compound type than what you're ordering, your product isn't covered by that clearance. Ask for the clearance certificate and check that the device description matches your spec. (We've seen factories present a 510(k) certificate for a latex glove program as evidence of their nitrile clearance. It happens.)

No sample approval process. A factory that ships production without a pre-production sample approval step is a factory that doesn't expect to be held to a spec. The sample approval process — where you receive and approve a production sample before the full run begins — is the checkpoint that catches spec drift before it becomes a container problem.

For a full view of our OEM ODM Nitrile Gloves capabilities and how we structure private label programs, that page covers the process in more detail.

Accelerator-Free Private Label: The Specification That Opens Hospital Accounts

Standard nitrile gloves use thiuram and carbamate accelerators in the vulcanization process. These accelerators are the primary cause of Type IV delayed hypersensitivity reactions in healthcare workers — a compliance concern that has moved from niche to mainstream in European hospital procurement over the past several years, and is gaining traction in US healthcare systems as well.

Accelerator-free nitrile uses a sulfur-donor cure system instead. The resulting glove has no detectable accelerator residue and passes EN 455 Part 4 (biological evaluation). For distributors supplying hospital groups, dental networks, or any procurement environment where Type IV allergy documentation is required, accelerator-free is the specification that gets you on the approved vendor list.

We run accelerator-free compound on a dedicated line at our facility — it's not a special project that requires setting up a new process. The MOQ is the same as standard: one 40HQ container. The compound is mixed in-house, which means we control the accelerator-free specification the same way we control our standard formulation — not dependent on a third-party supplier's batch consistency.

If you're building a private label line for US healthcare distribution and you're not sure whether your target accounts require accelerator-free, the practical answer is: ask your top three hospital or clinic accounts whether they have a Type IV allergy policy for glove procurement. If any of them do, accelerator-free is the specification you need. It's easier to launch with the right compound than to requalify a product after your first hospital tender.

Frequently Asked Questions

What is the MOQ for private label medical nitrile gloves?

One 40HQ container — approximately 2,000 boxes for standard examination glove SKUs (100 gloves per box). This applies to both standard OEM programs (factory formulation, your brand) and accelerator-free compound SKUs. Custom formulation ODM projects start at the same container minimum but include a formulation development phase before production.

Do I need my own FDA 510(k) clearance to sell private label nitrile gloves in the US?

No. FDA 510(k) clearance is a device clearance held by the manufacturer. When you sell private label gloves manufactured under the factory's cleared specification, you reference the factory's 510(k) clearance number in your product documentation. The factory should provide a letter of authorization confirming your branded SKU is covered by their clearance. You don't obtain a separate clearance for your label.

What ASTM D6319 documentation should I request from the factory?

Request a lot-level test report — not a generic certificate — showing actual measured values for tensile strength, elongation before and after aging, and AQL hole test results for the specific production run. A certificate that says "meets ASTM D6319" without measured values is not useful documentation for your compliance file or for responding to customer audits.

What's the difference between AQL 1.5 and AQL 2.5 for medical gloves?

AQL (Acceptable Quality Level) defines the maximum acceptable defect rate per lot at a given sampling confidence level. AQL 1.5 is tighter than AQL 2.5 — it means fewer defective units per lot are accepted before the lot is rejected. For medical examination gloves going into US healthcare distribution, AQL 1.5 is the standard that keeps complaint rates low at the distribution level. If a factory quotes AQL 2.5 as their standard, ask whether AQL 1.5 is available and at what cost — the answer tells you how they think about quality.

Can I add accelerator-free nitrile to my private label SKU mix without a higher MOQ?

Yes. At our facility, accelerator-free compound runs on a dedicated line with the same one-container MOQ as standard nitrile. There's no formulation development cost because the compound is already in production rotation. You specify accelerator-free in your spec sheet, and we produce to that spec the same way we produce standard SKUs.

How do I verify that a factory's FDA 510(k) clearance actually covers the gloves I'm ordering?

Request the clearance certificate and check the device description against your spec. The clearance covers a specific device — thickness range, material, intended use. If you're ordering a 0.08–0.10mm powder-free nitrile examination glove and the factory's clearance was issued for a different specification, your product isn't covered. You can also verify 510(k) clearances directly through the FDA's 510(k) database using the clearance number the factory provides.

—

If you're ready to move forward with a private label program, the fastest path is to send us your target spec — glove grade (exam or surgical), size run, target thickness, compound type (standard or accelerator-free), and annual volume estimate. We'll confirm MOQ fit, provide a spec sheet draft under your brand name, and send samples for approval before production begins. Request Quote or browse our full Medical Nitrile Gloves range to see the standard SKUs available for private label.

The US medical nitrile glove market runs on a layered supply chain. At the top are a handful of large national distributors who stock FDA-cleared product and can ship next-day to hospital systems. Below them sit regional medical supply companies, specialty PPE distributors, and a growing tier of direct-import buyers who have cut out the middle layer entirely. If you're building a procurement shortlist, understanding which tier each supplier operates in — and what that means for your unit cost, lead time, and compliance documentation — matters more than any ranked list.

This guide covers 10 real suppliers active in the US medical nitrile glove market, explains what each model is built for, and lays out the trade-off logic for when local stocking makes sense versus when factory-direct sourcing improves your landed cost and margin.

What Serious Procurement Teams Check Before Signing a Supplier

Before the shortlist, the criteria. Most hospital and clinic procurement teams are evaluating on five dimensions — and the weight of each shifts depending on whether you're buying for emergency stock or annual contract volume.

FDA 510(k) clearance is the baseline for exam-grade medical nitrile gloves in the US market. A supplier who can't produce a 510(k) number for the specific SKU you're buying is not a compliant source for clinical use. (We see this more than you'd expect — distributors listing "medical grade" product that traces back to an industrial-grade compound with no 510(k) on file.)

AQL inspection standard tells you how the gloves were tested before they left the factory. AQL 1.5 is the standard for medical-grade product under ASTM D6319. AQL 2.5 is common in industrial supply chains and gets misrepresented as equivalent. It isn't — at AQL 2.5, a lot with 2.5% defective units passes inspection. For clinical use, that's a meaningful difference.

Lot traceability and pre-shipment documentation matter when a container arrives and your receiving team needs to match the physical product to the compliance paperwork. Ask any supplier for a sample pre-shipment documentation package before you commit. If they can't produce one quickly, that's a signal about how their QC system is actually organized.

MOQ and inventory depth determine whether a supplier can serve your volume reliably across a full contract year — not just the first order. A distributor with shallow warehouse stock can fill a rush order but may not be able to hold spec consistency across 12 months of repeat orders.

Accelerator-free availability is increasingly relevant for hospital procurement, particularly in systems that have moved to Type IV allergy protocols. Not every supplier stocks accelerator-free nitrile as a standard SKU — some treat it as a special-order item with longer lead times and higher minimums.

The 10 Suppliers on the US Market Shortlist

These are real companies operating in the US medical nitrile glove supply chain. The list covers national distributors, regional medical supply companies, specialty PPE distributors, and one factory-direct manufacturer. Supplier type is noted for each — because the type determines the trade-offs, not the brand name.

—

1. Medline Industries — medline.com

Supplier type: National distributor / private-label manufacturer

Medline is the largest privately held medical products company in the US and one of the most significant players in hospital glove procurement. They distribute both branded and private-label nitrile gloves under their own Medline label, with FDA-cleared product across exam and procedure grades. Their supply chain infrastructure — regional distribution centers, EDI ordering, and GPO contract coverage — makes them the default choice for large hospital systems that prioritize procurement simplicity over unit cost optimization.

The trade-off: Medline's pricing reflects their distribution overhead and GPO margin structure. For high-volume buyers outside the GPO system, the unit economics are harder to justify against direct-import alternatives.

—

2. Henry Schein — henryschein.com

Supplier type: National distributor (dental, medical, and veterinary)

Henry Schein serves dental offices, physician practices, and ambulatory care facilities across the US. Their nitrile glove catalog covers exam-grade product from multiple manufacturers, with FDA 510(k) documentation available on request. For smaller clinic and practice accounts, Henry Schein's account management model and next-day delivery network are genuine advantages — the convenience premium is real, but so is the service.

Where they're less competitive: large-volume hospital procurement and private-label OEM. Henry Schein is a distributor, not a manufacturer, so customization options are limited to what their upstream suppliers offer.

—

3. McKesson Medical-Surgical — mckesson.com

Supplier type: National distributor / healthcare supply chain

McKesson is one of the three largest healthcare distributors in the US. Their medical-surgical division stocks nitrile exam gloves across multiple brands and grades, with deep integration into hospital GPO contracts (Vizient, Premier, HealthTrust). For IDN procurement teams working within an existing GPO framework, McKesson is often the path of least resistance.

The limitation is the same as any large distributor: you're buying through a supply chain layer, not from the source. Compliance documentation, lot traceability, and custom specification requests all route through McKesson's supplier relationships rather than directly to the factory.

—

4. Owens & Minor — owens-minor.com

Supplier type: National distributor / healthcare logistics

Owens & Minor operates one of the largest healthcare distribution networks in the US, with a focus on acute care and surgical supply. Their nitrile glove portfolio includes both commodity exam gloves and surgical-grade product. For hospital systems that have consolidated their supply chain through Owens & Minor's Byram or Halyard-branded programs, glove procurement often runs through existing account structures.

(Owens & Minor acquired Halyard Health's S&IP division in 2018 — so some product lines that buyers know under the Halyard name now route through Owens & Minor's distribution infrastructure.)

—

5. Cardinal Health — cardinalhealth.com

Supplier type: National distributor / private-label

Cardinal Health is the third major national healthcare distributor alongside McKesson and Owens & Minor. Their Flexal nitrile exam glove line is one of the more widely specified private-label products in US hospital procurement. FDA 510(k) cleared, available in powder-free formulations, and stocked across their distribution network.

For procurement teams already in the Cardinal Health ecosystem, Flexal is a straightforward specification. For buyers outside that ecosystem, the pricing and MOQ structure is less flexible than regional or direct-import alternatives.

—

6. Ansell Healthcare — ansell.com

Supplier type: Global PPE manufacturer with US distribution

Ansell is a global manufacturer — not a distributor — with manufacturing operations in Malaysia and other locations. Their Micro-Touch and TouchNTuff nitrile lines are widely specified in US hospital and laboratory settings. FDA 510(k) cleared, with AQL 1.5 inspection and documented lot traceability.

Ansell's position in the market is interesting: they're a manufacturer selling through distribution, which means you get manufacturer-level compliance documentation but distributor-level pricing. For buyers who want manufacturer accountability without managing a direct import relationship, Ansell is a credible middle option.

—

7. Kimberly-Clark Professional — kcprofessional.com

Supplier type: Global manufacturer / branded product

Kimberly-Clark's Purple Nitrile exam glove is one of the most recognized branded products in US clinical settings. FDA 510(k) cleared, with a distinctive formulation that has built strong end-user preference in surgical and procedure environments. For distributors serving accounts where brand preference drives the specification, Purple Nitrile commands a premium that holds.

The trade-off for procurement teams: brand premium is real and consistent. If your accounts are brand-agnostic and buying on compliance spec and unit cost, there are more cost-effective options at equivalent AQL and certification levels.

—

8. Dynarex Corporation — dynarex.com

Supplier type: Medical supply manufacturer / distributor hybrid

Dynarex is a US-based medical supply company that manufactures and distributes a broad range of disposable medical products, including nitrile exam gloves. Their product line covers powder-free nitrile in standard exam grades, FDA 510(k) cleared, with distribution through medical supply dealers and online channels. Dynarex occupies a mid-market position — more accessible MOQs than the large national distributors, with reasonable compliance documentation.

For regional medical supply distributors and smaller clinic accounts, Dynarex is a practical option where the large GPO-integrated distributors are oversized for the account.

—

9. Protective Industrial Products (PIP) — pipusa.com

Supplier type: Safety and PPE distributor

PIP is primarily an industrial safety distributor, but their medical-grade nitrile glove catalog has expanded significantly since 2020. They carry FDA-cleared exam gloves alongside their industrial PPE line, which makes them a practical single-source option for facilities that need both clinical and industrial nitrile product. Their distribution network covers industrial, healthcare, and government accounts.

The caveat: PIP's core competency is industrial PPE, not medical compliance. For hospital procurement teams with strict documentation requirements, verify the specific SKU's 510(k) status and AQL inspection records before specifying.

—

10. Glovemfg (Qingdao Glovemfg Medical Products Co., Ltd.) — glovemfg.com

Supplier type: Factory-direct manufacturer (China, exporting to US market)

We're on this list because we're a real option for US buyers who have outgrown the distributor model — and being transparent about what that means is more useful than pretending we're a domestic supplier.

We've been manufacturing nitrile gloves since 2007. The facility in Qingdao runs 8 fully automated dipping lines across 18,000 square meters, with annual output at 1.2 billion pieces. Our medical nitrile gloves carry FDA 510(k) clearance, CE marking, EN 455, and ASTM D6319 certification. AQL 1.5 inspection is standard — not an upgrade tier. We run 100% online pinhole detection on every line.

What makes the factory-direct model work at volume: when you're buying through a national distributor, you're paying for their warehousing, their account management infrastructure, and their margin. At container-scale repeat procurement — roughly 2,000 boxes per container as a starting point — the landed cost difference is significant enough to change the unit economics of your distribution business. We've seen US distributors move from GPO-sourced product to direct-import and recover 15–25% on landed cost, depending on the SKU and their existing freight relationships.

The honest trade-offs: lead time from order to container is longer than domestic stock. We're not the right answer for a 500-box emergency order that needs to ship tomorrow. We are the right answer for a buyer who knows their annual volume, wants to own their compliance documentation directly, and is ready to run a 12-month supply agreement instead of spot-buying through a distributor.

(We also support OEM private-label — if you're building your own brand on medical nitrile, we can run your label from the same lines that produce our FDA-cleared standard product. MOQ for OEM starts at one container.)

—

Where Local Distribution Earns Its Premium

Before making the case for factory-direct, it's worth being direct about when local distribution is the right answer — because it genuinely is, in specific scenarios.

Emergency and short-cycle replenishment: If a hospital system burns through stock faster than projected, or a clinic needs to cover a supply gap within 48 hours, a national distributor with regional warehouse coverage is the only viable option. No factory-direct relationship solves a same-week emergency.

GPO contract compliance: Many hospital systems are contractually obligated to source through GPO-approved suppliers. If your procurement is governed by a Vizient, Premier, or HealthTrust contract, the GPO framework determines your supplier options regardless of unit cost comparisons.

Low-volume accounts: For a small clinic buying 50–100 boxes per quarter, the economics of direct import don't work. The container MOQ, the freight management, and the customs documentation overhead are all sized for buyers operating at higher volume. A regional distributor is the right fit.

Brand-specified accounts: Some end-user accounts specify by brand — Kimberly-Clark Purple Nitrile, for example, has genuine end-user preference in certain surgical environments. If your downstream customer is specifying by brand, you're buying that brand regardless of the sourcing economics.

The local distribution premium is real and justified in these scenarios. The question is whether your procurement volume and contract structure put you in a position to capture the cost difference that factory-direct sourcing offers.

The Cost of the Distribution Layer at Scale

For buyers operating at container-scale volume — annual procurement in the range of 500,000 to several million pairs — the distribution layer has a measurable cost. It's not a criticism of distributors; it's the arithmetic of how supply chains work.

A national distributor sources product from manufacturers (often overseas), warehouses it domestically, manages their own compliance and logistics infrastructure, and sells it with a margin that covers all of that. That margin is typically 20–40% above the manufacturer's export price, depending on the product tier and the distributor's cost structure. For commodity exam gloves — a product where the compliance spec is standardized and the differentiation is thin — that margin is the primary variable in your landed cost.

At 1 million pairs per year, a 20% cost difference is a number that shows up clearly in your P&L. At 5 million pairs, it's a sourcing decision that determines whether your distribution business is competitive in your market.

The factory-direct model doesn't eliminate all overhead — you're taking on freight management, customs clearance, and pre-shipment inspection coordination. But for buyers with the volume and operational capacity to manage a direct import relationship, the economics are straightforward.

Matching Sourcing Route to Procurement Scenario

Scenario	Recommended Sourcing Route
Emergency stock, 48-hour need	National distributor (Medline, McKesson, Cardinal Health)
GPO-contracted hospital system	GPO-approved distributor per contract terms
Small clinic, <200 boxes/quarter	Regional distributor or Dynarex
Brand-specified account (Purple Nitrile, etc.)	Branded manufacturer's distribution channel
Mid-size distributor, 500K+ pairs/year	Evaluate factory-direct; run landed cost comparison
Private-label OEM, building your own brand	Factory-direct manufacturer with OEM capability
Annual contract, 1M+ pairs, cost-sensitive	Factory-direct import; container-scale economics apply
Accelerator-free specification, EU or US hospital	Verify with manufacturer directly; not all distributors stock

The decision isn't binary. Some buyers run a hybrid model: domestic distributor for emergency and spot orders, factory-direct for their base annual volume. That structure captures the convenience of local stock for exceptions while recovering the cost difference on the bulk of their procurement.

Verifying Compliance Before You Commit

One practical note on FDA 510(k) verification: the FDA's 510(k) database is publicly searchable at accessdata.fda.gov. Before finalizing any supplier for clinical use, search the specific product name or the manufacturer's name and confirm the clearance number matches the SKU you're buying.

We've seen situations where a distributor's catalog lists a product as "FDA cleared" but the clearance on file is for a different size, formulation, or even a different product entirely. The 510(k) number should be on the product packaging and traceable to a specific device listing. If a supplier can't provide that number on request, that's a compliance gap worth taking seriously before a container ships.

For EN 455 compliance in European markets, the same principle applies — the notified body certificate should reference the specific product and manufacturing site, not just the company name.

Factory-Direct as a Strategic Sourcing Layer

If your procurement volume puts you in the range where factory-direct economics make sense, the evaluation process is straightforward. Request a pre-shipment documentation package — this should include the 510(k) clearance number, AQL inspection report for the specific lot, material safety data, and the certificate of conformance. A manufacturer who can't produce this package quickly is not organized for compliant medical export.

For our part, we've been shipping to US healthcare distributors since our early years. The documentation package is standard, the AQL 1.5 inspection is built into the production process rather than bolted on at the end, and our in-house compounding lab means we can hold formulation consistency across a full year's worth of orders — not just the first sample shipment.

If you're evaluating a direct-import relationship for your medical nitrile gloves procurement, the most useful first step is a landed cost comparison against your current distributor pricing. We can provide FOB pricing, standard freight estimates for your destination port, and a sample documentation package so you can run that comparison with real numbers. Request a quote with your target volume, size mix, and any specification requirements — accelerator-free, specific thickness range, OEM label — and we'll respond with a detailed breakdown.